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This study investigated the effectiveness of an energy drink (ED) in enhancing 
cycling time-trial performance, and cognitive performance at rest, during moderate-
intensity exercise, and after exercise. The protocol was double-blind, randomized, 
placebo-controlled, two-period, and within-subjects. The treatments were ED containing 
caffeine and carbohydrate, and a caffeine-free non-caloric flavored placebo beverage 
(PLA). Exercise performance was measured by time to finish a simulated 35 km time-
trial course. Cognitive performance was measured by a Stroop task, a tapping task, a 
reaction time task, and an executive function task consisting of both tapping and reaction 
time. The effects of ED on blood markers were also assessed. Race performance was 
enhanced by an average of 3% when participants had ED compared to PLA without a 
difference in rating of perceived exertion (RPE). Performance was improved by ED even 
in participants that arrived to the lab with elevated blood caffeine concentrations. Both 
before and after the exercise, ED resulted in more taps per second in the tapping task. 
After receiving ED, plasma insulin spiked, there was a fall in free fatty acids (FFA) and 
 vii
blood glucose remained unchanged. Exercise onset caused a drop in blood glucose when 
participants consumed ED, though glucose returned to a level that was not different from 
PLA by 29 km into the race. FFA also increased as the exercise continued, and were not 
different from PLA by 23 km. ED elevated plasma caffeine levels. Epinephrine was 
elevated due to ED from 6 km to the end of the race. Norepinephrine was only elevated 
by ED at 6 km. At rest and throughout exercise ED caused elevated lactate 
concentrations. When participants consumed ED they sustained a greater VO2 and heart 
rate throughout the race. In summary, ED enhanced exercise performance and simple 
movement time as assessed by the tap test before and after intense exercise. There was 
enough caffeine in ED to enhance physical performance without causing negative effects 
on cognitive function. 
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Many athletic competitions are contested in a way that makes supplementation 
during exercise difficult. Attempting to supplement during a cycling time-trial that is 60 
minutes or less in duration is not desirable since race performance may suffer and the 
nutritional intervention will not have sufficient time to have full ergogenic effects. The 
ingestion of caffeine and carbohydrate in an energy drink have been demonstrated to 
have ergogenic effects when taken before exercise (Ivy et al., 2009). Additionally, energy 
drink consumption has been linked to enhanced reaction times and reduce reports of 
mental fatigue (Howard & Marczinski, 2010). The possibility that an energy drink can 
enhance cognitive performance during and after intense exercise has not been well-
studied. 
It has been shown that ingesting carbohydrates during prolonged aerobic activity 
can enhance athletic performance by increasing endurance (Coyle et al., 1986; Hulston & 
Jeukendrup, 2008; Ivy et al., 1983; Welsh et al., 2002; Yaspelkis et al., 1993) or work 
output in a specified time (Ivy et al., 1979). Carbohydrate supplementation prior to 
exercise onset has also been shown effective in some studies (Ivy et al., 2009; Kirwan, et 
al., 1998; Sherman et al., 1989) but not all (Foster et al., 1979; Hargreaves et al., 1987; 
Kovacs et al., 1998; Rollo & Williams, 2010).  The difference in results among the 
studies can be attributed to different types of carbohydrate ingested, other ingredients in 
the nutritional supplements, timing of the supplementation, and the type of exercise 
protocol utilized. 
When taken before or during exercise, caffeine exhibits ergogenic effects as 
demonstrated in multiple studies dating back to the early 20th century (Costill et al., 1978; 
Hulston & Jeukendrup, 2008; Ivy et al., 2009; Rivers & Webber, 1907; Spriet et al., 
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1992; Thornton et al., 1939). Traditionally doses of at least 3 mg caffeine per kg of body 
weight have been used to elicit the ergogenic effect (Costill et al., 1978; Essig et al., 
1980; Graham & Spriet, 1991, 1995; Hulston & Jeukendrup, 2008), though lower doses 
have been effective if co-ingested with carbohydrate (Alford et al., 2001; Ivy et al., 2009; 
Kovacs et al., 1998). 
At rest, caffeine and carbohydrates have been shown to improve performance on 
cognitive tasks. A caffeine and carbohydrate drink has been shown to enhance cognitive 
vigilance (Kennedy & Scholey, 2004), performance on rapid visual information 
processing, simple reaction time, and mood (Smit et al., 2004). If individuals are fasted 
carbohydrates and caffeine together boost performance on a letter finding task better than 
caffeine alone (Smit et al., 2004). Caffeine enhances simple reaction time, mood, and 
lowers perception of difficulty of cognitive tasks following 8 hours of caffeine abstinence 
(Heatherley et al., 2005). 
Carbohydrate supplementation during exercise attenuates decrements in cognitive 
performance if the exercise is sustained over several hours (Lieberman, 2003; Lieberman 
et al., 2002). Memory also is enhanced when blood glucose is elevated above fasting 
levels (Benton & Owens, 1993). 
Exercise itself may enhance, degrade, or have no effect on cognitive performance 
depending on the type of exercise protocol and type of cognition evaluated 
(Tomporowski, 2003). Steady-state exercise, specifically, may enhance not only reaction 
time, but some aspects of higher-level cognitive function (Lambourne, Audiffren, & 
Tomporowski, 2010a; Tomporowski, 2003). The effects appear to be transient and 
degrade immediately after exercise cessation (Lambourne, Audiffren, & Tomporowski, 
2010a). Memory may be enhanced by aerobic exercise as well (Coles & Tomporowski, 
2008). 
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It has been demonstrated that a combination of caffeine and carbohydrate can 
enhance both physical and cognitive performance during cycling exercise lasting greater 
than 2 hours (Hogervorst et al., 2008). What has not been unequivocally demonstrated is 
if an ED can produce the same cognitive and physical results in a shorter duration 
exercise setting. Furthermore, it is not clear if an ED will continue to enhance cognitive 
processes after completion of such an exercise. 
The purpose of this study was to investigate the effectiveness of an ED in 
enhancing cycling time trial performance, cognitive performance at rest, cognitive 
performance during moderate-intensity exercise, and cognitive performance immediately 
after completing a bout of moderate- to high-intensity exercise. Specifically we had the 
following hypotheses: 
Hypothesis 1: Consumption of 480 ml of an ED containing caffeine, 
carbohydrates, ginseng, glucuronolactone, guaraná, inositol, and taurine 60 minutes prior 
to starting a 35-km cycling time-trial race will result in a faster race time. 
Hypothesis 2: Consumption of the same ED 40 minutes prior to a set of cognitive 
tests including reaction time, movement time, and decision making will result in 
improved performance. 
Hypothesis 3: Consumption of the same ED will result in improved reaction time 
and decision making while exercising at 70% of VO2max immediately after completion of 
the 35-km time-trial race. 
Hypothesis 4: Consumption of the same ED will result in improved performance 
on reaction time, movement time, and decision making while sitting restfully 




The study was designed to evaluate the effects of a commercially available energy 
drink (ED) on cycling time-trial performance. The time trial was 35 km, was performed 
on a computer-controlled cycle ergometer, and lasted approximately 60 minutes for the 
participants to complete. The study also investigated the effects of ED on tests of mental 
acuity at rest, near completion of exercise, and post exercise. 
The experimental protocol was a double-blind, randomized, placebo-controlled, 
two-period, within-subjects crossover study. The two treatments were ED containing 
caffeine and carbohydrate, and a caffeine-free non-caloric flavored placebo beverage 
(PLA). Exercise performance was measured by time-to-complete the 35 km time-trial 
course performed on a cycle ergometer. Mental acuity was measured by a Stroop task, a 
tapping task, a choice reaction time task, and an executive function task consisting of 
both tapping and choice reaction time. The effects of ED on blood metabolites and 
hormones at rest and during exercise were also assessed. 
Participants 
Fifteen (8 male and 7 female) trained cyclists between 20 and 45 years of age 
were recruited from the Austin, TX area. Volunteers were invited to participate if healthy 
and if the recorded VO2max from a standardized ramping protocol was at least 45 
ml/kg/min for women or 55 ml/kg/min for men. Participants had a mean age of 31 years, 
mean body mass of 67.8 kg and 56.9 ml/kg/min was the mean VO2MAX. Complete 
participant characteristics are described in the appendix. 
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Study Supplement 
The 2 beverages were 480 ml of ED (160 mg caffeine, 54 g carbohydrate) and 
480 ml of PLA (caffeine-free non-caloric similarly-flavored placebo). The beverages 
were provided by SWSS Law (Corona, CA). A detailed list of ingredients for each drink 
can be found in the appendix. Each participant was randomly assigned to receive 1 of the 
drinks at his/her first experimental trial and the other drink at the second experimental 
trial at least 6 days later. The randomization procedure resulted in 8 participants receiving 
ED at the first experimental trial, while the other 7 participants received it at the second 
experimental trial. Beverages were served cold and participants were instructed to ingest 
them as quickly as possible without causing stomach discomfort. A single participant 
received the drinks at room temperature at her explicit request. 
Race Course 
The course was 35 km long and was programmed using Velotron 3D software 
(Version 3) that coordinated with the cycle ergometer (Racermate, Seattle, WA, USA). 
The course had flat portions to correspond with data collection at 0.75-1.25, 5-8, 16-18, 
and 28-30 km. Hills of 5.4% grade were placed at 11.75-12.25, 22.75-23.25, and 33.75-
34.25 km. The rest of the course was randomly created with no graded portion exceeding 
an absolute value of 3%. The net grade over the 35-km course was 1% uphill. The 
ergometer was equipped with a toggle to allow the participants to shift gears at will to 
adjust to the terrain. The details of the course are more specifically described in the 
appendix. 
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Mental Acuity Tests  
There were 4 tests of mental acuity. The mental acuity tests were given at 3 times: 
before consumption of the test beverage (Pre Drink, Pre Race), after beverage 
consumption/before exercise (Post Drink, Pre Race), and after exercise completion (Post 
Race). Each test measured a different aspect of mental acuity. The tests included a 
tapping task, choice reaction time, an executive function test (a choice reaction time test 
including “go” and “no-go” signals while participants simultaneously tap with their other 
hand), and a Stroop task that included two stimulus types. The Stroop task was 
implemented on a computer using Stroop Research software (Life Science Associates, 
Bayport, NY, USA). All other mental acuity tasks were conducted on a MOART reaction 
and movement time panel (Lafayette Instrument, Lafayette, IN, USA). 
DECISION MAKING 
The Stroop test presented color words on a computer screen (e.g., “red”, “green”, 
or “blue”) in two ways to assess decision making: “incongruent” and “read”. In 
“incongruent”, the words on the computer screen were presented in a font color that was 
incongruent with the word definition (e.g., the word “red” may be presented in a blue 
font). Correct responses were associated with a key corresponding to the font color. 
Alternatively, in “read”, the color word would appear with a box around it, and the 
correct response was associated with a key corresponding to the word definition. See the 




In the executive function test, participants tapped a button continuously with one 
hand while their other hand was holding down another “home” button. The non-tapping 
hand continued to hold the “home” button down until a red or green light appeared over 
another “movement” button. If the light was red, the participant moved to the 
corresponding “movement” button, but if the light was green the participant kept his or 
her hand on the “home” button while continuing to tap with the other hand. Decision 
making was assessed by the error rate. Every participant began with the right hand 
assigned to the “home” button and the left hand assigned to the “tap” button. In an effort 
to control for hand dominance, after five repetitions of the task, participants switched 
hand assignments and repeated the task (i.e. left hand was assigned to the “home” button 
and the left hand was assigned to the “tap” button). The process was repeated twice more 
so that a total of ten repetitions were recorded with each hand at the “home” button.  
PRECISION 
We assessed precision by instructing participants to hit the center of a button on 
the reaction time board in the tapping test as well as in the reaction time test. If a 
participant hit the button but not in the center, the hit was counted as an “outer rim” 
contact.  Precision was assessed by the percentage of total taps which did not hit the outer 
rim. 
REACTION TIME 
Three tests were used to assess reaction time:  Stroop, executive function and 
reaction time. The Stroop test and executive function test have been described. In the 
reaction time test participants were instructed to put their finger on a “home” button and 
keep it there until a green light appeared over another button. As soon as the green light 
appeared, participants moved their finger off of the “home” button and to the 
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“movement” button as quickly as possible. Reaction time was defined as the amount of 
time that it took a participant to remove their finger from the “home” button after a red 
light appeared during the executive function test. 
MOVEMENT TIME 
Movement time was measured in two ways: simple and gross. Simple movement 
refers to tapping speed in the tap and executive function tests; more taps per second is a 
result of an improvement in movement speed. Gross movement was assessed in the 
reaction time and executive function tests as how quickly participants moved to the 
“movement” button after removing their finger from the “home” button. 
Food, Exercise, and Sleep Logs 
Participants were given a log to record their habits for the 48 hours before the 
exercise visits (familiarization visit and experimental trials). The participants recorded all 
food ingested in the 24 hours before the exercise visits and were instructed to abstain 
from alcohol and caffeine. Additionally participants recorded exercise and sleep habits in 
the 48 hours prior to the exercise visits. The participants completed the logs prior to the 
familiarization visit in order to verify correct completion of the records, but the data was 
not analyzed. If the logs submitted by the participants at the familiarization visit indicated 
low energy intake (<1800 kcal/24 hours), low carbohydrate intake (<225 g/24 hours), 
high exercise (>3 hours of moderate intensity/48 hours), or low sleep (<14 hours of 
moderate quality/48 hours) then the participants were instructed to change their habits 
accordingly in the 2 days before the first experimental trial. If participants reported to the 
first experimental trial with values outside of these acceptable ranges, the trial was 
rescheduled: only one participant had to reschedule due to inadequate sleep. 
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Participant Health and Safety Procedures 
At each visit to our lab after the screening visit participants reported any newly 
occurring illnesses, diseases, or injuries. An Adverse Event Form was completed by the 
investigators in these circumstances. Of the adverse events reported, none were thought 
to be related to the treatment drinks. A male participant was dropped from the study after 
partial completion after he suffered injuries in a bicycle wreck unrelated to the research 
study. Another male participant reported knee pain that he attributed to the cycle 
ergometer used in the research: the investigators offered to reschedule the participant’s 
experimental trials to allow his pain to subside, but he claimed the knee pain did not 
affect his exercise performance since it only onset approximately 24 hours after he 
completed the time-trial rides. 
Screening Visit and Preliminary Testing 
The study was approved by the Institutional Review Board at The University of 
Texas at Austin prior to any participant recruitment or screening procedures. After an 
initial contact by telephone or email, a volunteer was invited to participate in a screening 
visit. At the screening visit a detailed explanation of the experimental procedures and the 
potential risks of the study were given both verbally and in writing to all potential 
participants. Volunteers were given the opportunity to ask questions before signing the 
informed consent, according to the protocol described in the University of Texas at 
Austin’s ‘Institutional Review Board Procedures Manual for Faculty, Staff and Student 
Researchers with Human Subjects’. All volunteers gave informed consent in writing prior 
to any biomedical research project-specific procedures. 
After the informed consent was signed, the volunteer completed the Health 
Screener. The volunteer was only invited to participate in the study if he/she answered 
 10
“no” to questions on the Health Screener pertaining to hypertension, circulatory, liver 
and kidney conditions, pregnancy and diabetes. Nutritional supplements were acceptable 
only if the volunteers agreed to discontinue use for at least 1 week prior to the follow-up 
visit and would maintain abstinence throughout the duration of the study. Prescription 
medications were acceptable only if the dosage had been constant for at least 2 months 
leading up to the screening. 
After the Health Screener the volunteer completed the Study Screener. Volunteers 
were permitted to proceed with the screening visit if their reported weekly cycling 
exercise was at least 3 hours of moderate intensity. Each hour of low-intensity or high-
intensity cycling exercise was considered equivalent to 0.5 or 1.5 hours of moderate-
intensity cycling exercise. Volunteers were permitted to proceed with the screening visit 
if their reported daily caffeine consumption was approximately 200 mg or less: 
volunteers that willingly agreed to reduce daily consumption to meet this requirement 
were also permitted to continue with the screening visit. 
After finishing the Study Screener the volunteer submitted to a blood-pressure 
recording. If the volunteer had systolic blood pressure in excess of 140 mmHg or 
diastolic blood pressure in excess of 90 mmHg the volunteer was not permitted to 
participate in the study. 
The volunteer then completed a brief intelligence test, the Kaufman Brief 
Intelligence Test (KBIT2) (Psychcorp, San Antonio, TX, USA). The results of the test 
were not used for screening purposes and this was explained to volunteers to help 
attenuate anxiety. 
Finally the volunteer performed a ramping exercise protocol on a Velotron cycle 
ergometer (RacerMate, Seattle, WA, USA) while breathing into a TrueOne 2400 
metabolic cart (ParvoMedics, Sandy, UT, USA) in order to assess VO2max. Male 
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volunteers with a VO2MAX of at least 55 ml/kg/min were invited to participate in the study 
while the minimum qualifying VO2max for females was 45 ml/kg/min. 
If the volunteers satisfied all of the criteria he/she was invited to participate in the 
study and the remaining visits were scheduled. 
VO2MAX TEST 
The VO2MAX test required volunteers to maintain a cadence of at least 60 RPM on 
a cycle ergometer for as long as possible while the resistance on the ergometer continued 
to increase over time. Specifically, volunteers worked at a power output of 100 Watts for 
the first 2 minutes after which the resistance increased. For the first 10 minutes, the 
power output increased every 2 minutes by 50 Watts and 25 Watts for men and women, 
respectively. After 10 minutes of the ramp protocol, the power output continued to 
increase by 25 Watts every minute for both genders. When volunteers reached a work 
rate where a cadence of 60 RPM could not be maintained, the test was ended and 
participants were immediately put into a low-resistance cool-down ride. A single 
participant ended the test by his own volition due to reported difficulty in breathing 
through the Daniel’s valve: all other participants whose data appear in the results ended 
the VO2MAX test when the appropriate cadence could no longer be maintained. 
Throughout the ramp test volunteers’ gas exchange was analyzed by a metabolic cart. By 
the end of the VO2MAX test all participants had reached a heart rate (HR) within 10% of 
HRMAX as predicted by the formula proposed by Tanaka et al. (2001), had a respiratory 
exchange ratio (RER) above 1.10, and had a final VO2 recording that was not maximal 
(indicating VO2 had already plateaued). For the exercise visits participants rode at 50% of 
VO2MAX for a warm-up ride and at 70% of VO2MAX during the post-race Stroop task. The 
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Wattages necessary to elicit the appropriate O2 consumption were calculated using the 
formula from Åstrand and Rodahl (1977). 
Exercise Visits 
FAMILIARIZATION VISIT 
The familiarization visit was identical to the experimental trial visits except that 
no treatment drink was given to the participant and blood was not drawn. The participant 
completed baseline mental acuity tests upon arrival to the lab. The participant then 
consumed a volume of water equal the treatment drink volume (480 ml). The participant 
repeated the mental acuity tests 40 minutes after water consumption then engaged in a 
warm-up exercise at 50% of VO2MAX, a 35 km time-trial ride, a 2 min ride at 70% of 
VO2MAX while completing a Stroop task, and post-exercise mental acuity tests as outlined 
for the experimental trials below. Body mass, HR, RPE, and respiratory gas collection 
were gathered in identical fashion as the experimental trials. Water was provided to 
participants at the same regular intervals as in the experimental trials. The volume of 
water provided at the familiarization was a standard 800 mL, however participants 
received more water at the experimental trials to offset fluid loss experienced during the 
familiarization trial. For example, if a participant lost 1 kg of body mass during the 
familiarization, he/she was provided with 1800 mL of total water during each 
experimental trial (1000 mL in addition to the 800 mL at familiarization). After 
completion of the post-exercise mental acuity tests, the participants were provided a light 
meal. 
EXPERIMENTAL TRIALS 
The only difference between the experimental trials and the familiarization visit is 
that participants received the treatment drinks at the experimental trials and blood 
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samples were drawn at several times. The familiarization visit and experimental trials 
consisted of three blocks, pre time trial, time trial, and post time trial. The timeline for 
these visits can be found in the appendix. 
Pre Time Trial 
The participant was fitted with a heart-rate monitor (Polar RS400, Finland), 
weighed after urination, and completed a bout of mental acuity tests (described below). 
During the mental acuity tests resting HR was recorded. After the tests, the participant 
was equipped with a forearm intravenous catheter then blood was drawn. The participant 
ingested the treatment drink and rested for 40 minutes. After resting, the participant 
completed another bout of mental acuity tests after which a second blood sample was 
drawn. The participant used the restroom if needed then completed a 5-minute warm-up 
ride at 50% VO2MAX.  
Time Trial 
Immediately after the warm-up ride, the participant began the customized 35-km 
time trial (described in detail later). Throughout the time-trial ride the participant 
received a pre-determined volume of water throughout the time-trial ride to offset sweat 
loss. 
In addition to the 2 samples taken prior to exercise, blood was drawn at 5 times 
during the time-trial ride. Specifically blood was sampled when the participant had 
reached 6, 17, 23, 29, and 34 km of the course. 
Ventilation, VO2, CO2 production and RER were recorded at 3 times in the ride 
using the same metabolic system used for the VO2MAX test. Gas collection began when 
the participant crossed 5, 16, and 28 km and continued for 4 minutes. The course was 
designed so that these periods of gas collection were during flat race sections so that the 
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participants could achieve steady state.  The full 4 minutes of data was used in data 
analysis unless there was a delay in starting data collection, in which case all data up to 4 
minutes was analyzed.  
HR was recorded at several points during the 35-km course. Subjective rating of 
perceived exertion (RPE) on a Borg scale (unit-less scale ranging from 6 to 20) was 
obtained during exercise at the same times as HR. HR and RPE were collected at 1, 6, 12, 
17, 23, 29, and 34 km. The 12, 23, and 34 km markers were taken while participants were 
riding up a simulated hill at a 5.4% grade. 
Post Time Trial 
At the conclusion of the 35-km time trial, the participant began a 2-minute ride at 
70% VO2MAX while simultaneously completing the Stroop task. Immediately after the 
Stroop task the participant completed the post-exercise mental acuity tests. The 
participant’s HR was recorded at the start and every 30 seconds of the Stroop task. After 
completion of the mental acuity tests, the participant’s HR was recorded once more 
before the catheter was removed. The participant was weighed after urinating and was 
finally provided with a light meal. The heart-rate monitor was retrieved and instructions 
for the next trial were given to the participant. 
The time separating the experimental trials ranged from 6 to 21 days. The only 
difference between the first and second experimental trial was that the participant 
received the alternative treatment drink at the second experimental trial. 
Blood Tissue Preparation 
Each blood sample was mixed with EDTA (24 mg/ml, pH 7.4) in a ratio of 3 ml 
blood:0.23 ml of EDTA. A 0.5 ml sample of this anticoagulated blood was transferred to 
another tube containing 1 ml 10% perchloric acid. When ß-endorphins were measured, a 
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3 ml blood sample was added to 0.23 ml of EDTA and 0.18 ml of aprotinin (10.12 
units/ml) from bovine lung (Sigma-Aldrich, St. Louis, MO, USA). All tubes were 
centrifuged for 10 minutes at 3,000 rpm with a JS-7.5 rotor in a Beckman J2-21 
centrifuge. Plasma and perchloric acid extracts were transferred and stored at -80˚C for 
further analysis. Plasma samples were analyzed for caffeine, insulin, glucose, cortisol, 
human ß-endorphins, catecholamines, myoglobin and free fatty acids (FFA). Perchloric 
acid extracts were analyzed for glycerol and lactate. 
CAFFEINE 
Caffeine concentration was determined for the first blood draw (Pre Drink, Pre 
Race), the second blood draw (Post Drink, Pre Race), and the seventh blood draw (34 
km).  Caffeine was analyzed using a commercially available ELISA kit (Neogen 
Corporation, Lexington, KY, USA). The assay worked via competitive binding to a 
microwell. The microwells had a coat of antibodies bound to them which were specific 
for caffeine or a drug-enzyme conjugate that was provided in the kit. The sample and 
drug-enzyme conjugate were added to the microwells and incubated. After incubation the 
microwells were washed to remove unbound caffeine and drug-enzyme conjugates. K-
Blue Substrate (TMB) was added which was recognized by the drug-enzyme conjugate. 
After another 30 minutes of incubation Red Stop Solution was added. The microwells 
were read visually at 450 nm on a ELx800 microplate reader (Biotek, Winooski, VT, 
USA). Since only the drug-enzyme conjugate recognized the TMB, the presence of 
caffeine resulted in less blue color development. When duplicates were tested, they were 
tested within the same assay (intra-assay). The average coefficient of variation (CV) for 
intra-assay duplicates was 3.7%. 
 16
CATECHOLAMINES 
The catecholamines epinephrine and norepinephrine were analyzed from the first 
blood draw (Pre Drink, Pre Race), the second blood draw (Post Drink, Pre Race), the 
fourth blood draw (17 km), the sixth blood draw (29 km), and the seventh blood draw (34 
km). The catecholamines were analyzed using a commercially available ELISA kit 
(Rocky Mountain Diagnostics, Colorado Springs, CO, USA). The catecholamines were 
first extracted from the plasma samples using a cis-diol-specific affinity gel, acylated and 
then derivatized enzymatically. The extracts were then subjected to the assay. The assay 
worked via competitive binding to a microwell. The catecholamines and an analyte 
supplied with the kit competed for a limited number of sites within the microwell. After 
incubation, unbound catecholamines and analytes were washed away. An antibody bound 
to the analyte was recognized by an anti-rabbit antibody which then reacted with TMB. A 
stop solution was used and quantification of color development was performed at 450 nm 
by a ELx800 microplate reader (Biotek, Winooski, VT, USA). When duplicates were 
tested, they were tested within the same assay (intra-assay). The average CV for intra-
assay duplicates was 2.7% for epinephrine and 3.8% for norepinephrine. 
ß-ENDORPHINS 
β-endorphins were analyzed from the first blood draw (Pre Drink, Pre Race), the 
second blood draw (Post Drink, Pre Race) and the seventh blood draw (34 km). Prior to 
analysis, β-endorphins were extracted using a Strata well plate (Phenomenex, Torrance, 
CA, USA) and dried under nitrogen using a SpedVac (Savang Instruments, Farmingdale, 
NY, USA) and resuspended. β-endorphins were then analyzed using a commercially 
available ELISA kit (MD Bioproducs, St. Paul, MN, USA). The microplates provided in 
the kit were pre-coated with a secondary antibody with non-specific binding sites 
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blocked. A primary antibody was added  and the primary antibody was bound by either 
biotinylated peptide or the β-endorphins in the sample. The biotinylated peptide reacted 
with streptavidin-horseradish peroxidase (SA-HRP) in order to catalyze TMB to produce 
a blue solution. A stop solution of hydrogen chloride (HCl) was used to convert the blue 
to yellow color, and the intensity of the yellow color was read at 450 nm by a ELx800 
microplate reader (Biotek, Winooski, VT, USA). When duplicates were tested, they were 
tested within the same assay (intra-assay). The average CV for intra-assay duplicates was 
2.7%. 
INSULIN 
Insulin was analyzed from all blood draws (Pre Drink, Pre Race; Post Drink, Pre 
Race; 6 km; 17 km; 23 km; 29 km; and 34 km) using a commercially available RIA kit 
(MP Biomedicals, Solon, OH, USA). An antibody for insulin was bound to the inside of a 
polypropylene tube. A radioactive form of insulin containing 125I competed with the 
insulin from plasma samples for binding to the limited number of antibody sites within 
the tube. A 1470 Wallac Wizard Gamma Counter (PerkinElmer, San Jose, CA, USA) was 
used to determine the amount of binding of insulin-125I and a standard curve was used to 
determine the concentration of insulin in the plasma sample. When duplicates were 
tested, they were tested within the same assay (intra-assay). The average CV for intra-
assay duplicates was 1.5%. 
CORTISOL 
Cortisol was analyzed from all blood draws (Pre Drink, Pre Race; Post Drink, Pre 
Race; 6 km; 17 km; 23 km; 29 km; and 34 km). Cortisol was analyzed by a commercially 
available RIA kit (MP Biomedicals, Solon, OH, USA). An antibody for cortisol was 
bound to the inside of a polypropylene tube. A radioactive form of cortisol containing 125I 
 18
competed with the cortisol from plasma samples for binding to the limited number of 
antibody sites within the tube. A 1470 Wallac Wizard Gamma Counter (PerkinElmer, 
San Jose, CA, USA) was used to determine the amount of binding of cortisol-125I and a 
standard curve was used to determine the concentration of cortisol in the plasma sample. 
When duplicates were tested, they were tested within the same assay (intra-assay). The 
average CV for intra-assay duplicates was 1.9%. 
FREE FATTY ACIDS 
FFA were analyzed from all blood draws (Pre Drink, Pre Race; Post Drink, Pre 
Race; 6 km; 17 km; 23 km; 29 km; and 34 km) using a microfluorometric assay first 
outlined by Duncombe (1964) but then modified by Noma et al. (1973). FFA were 
extracted from plasma using chloroform, heptain, and methanol solution (CHM) and a 
copper reagent. The extract containing copper-bound FFA was mixed with a color 
reagent (22 mg diethyldithiocarbamate (DETC) and 10 ml butanol) in a ratio of 1:5. The 
sample was then read at 436 nm on a Beckman DU 640 spectrophotometer (Beckman, 
Brea, CA, USA) after 10 minutes of incubation. When duplicates were tested, they were 
tested within the same assay (intra-assay). The average CV for intra-assay duplicates was 
4.9%. 
GLUCOSE 
Glucose was analyzed for all blood draws (Pre Drink, Pre Race; Post Drink, Pre 
Race; 6 km; 17 km; 23 km; 29 km; and 34 km).using a Glucose Color Reagent kit 
(Cliniqa, San Marcos, CA, USA) incorporating a modified Trinder reaction. Samples and 
standards reacted with the reagent provided by the kit to form a red-violet quinone, which 
was visualized at 500 nm by a Beckman DU 640 spectrophotometer. When duplicates 
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were tested, they were tested within the same assay (intra-assay). The average CV for 
intra-assay duplicates was 0.7%. 
MYOGLOBIN 
Myoglobin was analyzed from all blood draws except 17 km (Pre Drink, Pre 
Race; Post Drink, Pre Race; 6 km; 23 km; 29 km; and 34 km). Myoglobin was 
determined by a solid phase ELISA using a commercially available kit (BioCheck, Foster 
City, CA, USA). An antibody specific for myoglobin was fixed to the inside of wells in a 
microplate. The samples and standards were added, incubated, and unbound sample was 
washed away. Another antibody specific for myoglobin was added, incubated, then 
unbound portions were washed away. The second antibody contained horseradish 
peroxidase so the addition of TMB resulted in evolution of a blue color. After a stop 
reaction, the color was read at 450 nm by a ELx800 microplate reader (Biotek, Winooski, 
VT, USA). When duplicates were tested, they were tested within the same assay (intra-
assay). The average CV for intra-assay duplicates was 8.3%. 
LACTATE 
Lactate was analyzed from the perchloric acid extracts from all blood draws (Pre 
Drink, Pre Race; Post Drink, Pre Race; 6 km; 17 km; 23 km; 29 km; and 34 km). Blood 
lactate was determined by enzymatic analysis according to Hohorst in Methods of 
enzymatic analysis (pp. 266-270, 1963). Samples and standards reacted with 
nicotinamide adenine dinucleotide (NAD) in the presence of lactate dehydrogenase 
(LDH) to form pyruvate and NADH. The pyruvate was reacted with hydrazine 
irreversibly to form pyruvate hydrazone. The NADH was visualized at 340 nm by a 
Beckman DU 640 spectrophotometer. When duplicates were tested, they were tested 
within the same assay (intra-assay). The average CV for intra-assay duplicates was 0.8%. 
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GLYCEROL 
Glycerol was analyzed from the perchloric acid extracts from all blood draws (Pre 
Drink, Pre Race; Post Drink, Pre Race; 6 km; 17 km; 23 km; 29 km; and 34 km). Blood 
glycerol was determined by enzymatic analysis as specified by Weiland in Methods of 
enzymatic analysis (pp. 1404-1409, 1974). The samples and standards were reacted with 
NAD and ATP in the presence of glycerol kinase (GK) and glycerol-3-phosphate 
dehydrogenase (GPDH). The measured product of the reaction was NADH, which was 
visualized at 340 nm by a Beckman DU 640 spectrophotometer. When duplicates were 
tested, they were tested within the same assay (intra-assay). The average CV for intra-
assay duplicates was 6.2%. 
Statistics 
Data were analyzed using a two-factor (treatment-by-time) repeated-measures 
ANOVA using SPSS version 19 (IBM, Armonk, NY, USA). Where interactions or main 
effects were observed, pairwise comparisons were made and differences were considered 
significant at p <.05 using the least significant difference (LSD) post-hoc test. Data are 
expressed as means  standard error of the mean.
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RESULTS 
All descriptive statistics and raw data used for inferential statistics are reported in 
the appendix. Figures were generated when statistically significant results were found and 
are also provided in the appendix. 
Physical Performance 
TIME TO FINISH 
A significant treatment effect was found as every participant finished the 35-km 
time trial in a shorter time after consuming ED as compared to PLA. The average 
improvement was 2.0±1.3 minutes. This was an average of 3% improvement in time trial 
performance. 
Of the 15 participants, 5 arrived to the laboratory with baseline blood caffeine 
concentrations of greater than 1000 ng/ml at both experimental trials. All participants 
claimed to have followed the instructions to abstain from caffeine for at least 24 hours. 
Data was split so that the participants with high-baseline caffeine levels at both 
experimental trials were analyzed separately than those with low-baseline caffeine levels. 
The effects of ED on exercise performance were unchanged, such that regardless of 
baseline caffeine levels, ED resulted in an average time-trial performance improvement 
of 3%. Furthermore, regardless of baseline caffeine levels, blood caffeine elevated after 
consumption of the ED (379 ng/ml to 2324 ng/ml and 1842 ng/ml to 3196 ng/ml in the 
low and high baseline groups, respectively). 
RATING OF PERCEIVED EXERTION 
There was no difference in RPE between trials. RPE was significantly increased 
throughout the trials regardless of treatment. 
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Cognitive and Psychomotor Performance 
DECISION MAKING 
No effects of time or treatment were found on decision making ability in the 
Stroop test or executive function test. 
PRECISION 
There was no difference in precision as assessed by the reaction time test. A main 
effect for treatment was seen for precision when assessed by the tap test, with ED 
resulting in less precision than PLA. While the difference is statistically significant, the 
difference is not clinically relevant as it was less than 1%. 
REACTION TIME 
There was no change in reaction time due to ED as assessed by the reaction time 
or Stroop tests. When examining total time to complete the executive function test 
(including reaction time and movement time), a main effect for treatment was found 
though there was no interaction of time by treatment. Since no time by treatment 
interaction was found, and participants were faster even before receiving ED (see the 
“Pre Drink, Pre Race” time), it cannot be concluded that the ED caused faster 
performance on the test; participants may have been performing the task faster on the day 
they received ED due to uncontrolled confounding variables.  
Participants had faster reaction times on the Stroop test after completing the 35-
km race as demonstrated by a main effect for time. The main effect for time was found 
for the “incongruent” stimuli but not the “read” stimuli.  Since these were the only two 
stimuli types in the Stroop test, the overall main effect is due to the improvement in 
performance on the “incongruent” stimuli specifically. 
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MOVEMENT TIME 
A treatment-by-time interaction was found for simple movement time as assessed 
by the tap test. A main effect for treatment was also found. ED resulted in more taps per 
second compared to PLA both before exercise started and after the 35-km time trial. The 
data was further analyzed by splitting the participants into separate groups for low- and 
high-baseline caffeine. It was found that there were no statistically significant effects for 
the high-baseline caffeine group. The low-baseline caffeine group had a treatment-by-
time interaction, but post-hoc analysis revealed that there was only a significant 
difference from PLA before exercise. 
Simple movement was also assessed by the executive function test. Main effects 
for both treatment and time were found, though there was no treatment-by-time 
interaction. Simple movement speed increased after exercise with both treatment drinks. 
While participants were faster on the day they received the ED, conclusions about ED’s 
effects cannot be made due to a lack of interaction. 
Gross movement time was also assessed. When assessed by the reaction time or 
the executive function test, participants demonstrated faster gross movement times after 
exercise as indicated by a main effect for time. A treatment effect was not seen as there 
were no interactions of treatment-by-time nor were main effects for treatment observed. 
Metabolic Effects 
PLASMA SUBSTRATES 
Treatment-by-time interactions were significant for insulin, blood glucose and 
free fatty acids. Main effects for treatment were also significant. Insulin was at fasting 
levels before receiving a treatment drink at both visits. After receiving ED, plasma 
insulin spiked, occurring concomitantly with a fall in free fatty acids while blood glucose 
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remained unchanged. The exercise onset caused a drop in blood glucose when 
participants consumed ED, though glucose returned to a level that was not statistically 
different from PLA by 29 km into the race. Free fatty acids also increased as the exercise 
continued, and were not statistically different from PLA by 23 km into the race. 
There was no treatment-by-time interaction for glycerol. Regardless of treatment 
drink provided, glycerol remained unchanged at rest then rose throughout the duration of 
exercise. 
CAFFEINE, CATECHOLAMINES, Β-ENDORPHINS AND CORTISOL 
Treatment-by-time interactions were significant for caffeine, epinephrine and 
norepinephrine. Main effects for treatment were also found. ED elevated plasma caffeine 
levels throughout the race. At rest, neither catecholamine tested was affected by ED. 
Epinephrine was elevated due to ED at 6 km and remained above PLA until the end of 
the race. Norepinephrine was only different between ED and PLA at 6 km. 
No treatment-by-time interaction was found for β-endorphins; however, there was 
a main effect for time. Plasma concentrations fell from baseline values when participants 
were resting, and rose due to exercise. There was no difference at rest or at the conclusion 
of exercise between the treatments. 
There was a main effect of time for cortisol. Participants had elevated levels of 
cortisol at the end of the exercise regardless of treatment. 
PHYSIOLOGICAL INDICATORS OF WORK OUTPUT 
A treatment-by-time interaction was found for lactate. A main effect for treatment 
was also found. The carbohydrates ingested in ED generated lactate in participants at rest. 
Throughout the exercise ED maintained lactate concentrations greater than those seen in 
PLA. 
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Plasma myoglobin was measured at rest and throughout the exercise trials. There 
was a main effect for time, though no at no time was there a significant change from 
baseline as indicated by post-hoc testing. 
Main effects for treatment and time were found for VO2 measured throughout the 
exercise trials. The RER had a main effect by time but was not affected by the treatment. 
Over the course of the race, oxygen consumption fell, though when participants 
consumed ED they sustained an overall greater VO2. RER fell over the course of the race 
also, though no main effect for treatment was observed. 
Although there was no treatment-by-time interaction, there were main effects for 




The current study evaluated the effects of ED on physical, cognitive and 
psychomotor performance, and metabolism at rest and during exercise.  The primary 
finding was that the ED enhanced aerobic exercise performance. Every participant 
completed the cycling time-trial faster when they had ED compared to PLA. The average 
time to finish was improved by more than 3%. Furthermore, there was no difference in 
RPE between trials despite the fact that when participants received ED they had an 
increased exertion. The results clearly indicate that ED when provided prior to exercise 
enhances performance of trained cyclists. The enhanced performance is likely due to a 
combination of increased central drive and sympathetic output from caffeine acting as an 
adenosine antagonist in conjunction with readily available carbohydrate for rapid 
oxidation.  However, it cannot be ruled out that the micronutrient composition of ED had 
a positive influence on exercise performance. 
The current findings are in agreement with other research that has evaluated the 
effects of energy drinks on exercise performance. Ivy et al. (2009) found an improvement 
in cycling time-trial performance using Red Bull energy drink. Ivy et al. (2009) used a 
similar time-trial protocol to the current study and also provided the energy drink 40 
minutes before the time trial, so it is not surprising that our results are similar. Alford et 
al. (2001) demonstrated that consuming Red Bull energy drink resulted in enhanced 
ability to sustain work output at a an exercise intensity that elicited 65-75% of HRMAX. It 
has also been shown that consumption during exercise can be of benefit. In the study by 
Geiβ et al. (1994) participants had improved performance when  provided Red Bull 
energy drink 30 minutes into an exercise bout at 70% of VO2MAX lasting 1 hour, followed 
by an exercise test of increasing intensity to volitional fatigue. Similar to these previous 
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studies, the current study compared an energy drink containing both caffeine and 
carbohydrates to a non-caloric caffeine-free placebo drink. 
The effect of caffeine and carbohydrate combined on exercise performance has 
been studied previously. Kovacs et al., (1998) demonstrated that caffeine added to 
carbohydrates improved cycling time trial performance greater than carbohydrates alone. 
In the study, participants consumed an average of 1026 ml of a placebo or 1 of 4 
treatment drinks containing a total of 71 grams of carbohydrate and 0, 154, 230, or 328 
mg of caffeine. The treatments were standardized so that participants drank a total of 14 
ml/kg with 68.8 g/l of carbohydrate and 0, 150, 225, or 325 mg/l of caffeine. The doses 
were divided such that 57% of the total volume was ingested 55 minutes prior to a 1-hour 
time-trial ride while the rest of the drink was consumed during the exercise bout. The 
researchers found that the moderate and high doses of caffeine improved performance on 
the time-trial ride greater than the carbohydrate alone, while the consumption of any of 
the treatment drinks improved performance compared to placebo. There were no 
statistically significant differences in performance between the carbohydrate-only and 
low-caffeine supplement. 
The research by Kovacs (1998) indicates that the addition of at least 225 mg of 
caffeine to a solution of 71 grams of carbohydrate enhances performance greater than the 
ingestion of carbohydrates alone. When the caffeine concentration was below 225 mg it 
had no additive effect with carbohydrate on performance.  By contrast ED in the current 
study provided participants with lower doses of both ingredients (54 g of carbohydrate 
and 160 mg of caffeine). However, since we did not use a carbohydrate-only control 
treatment as in the research by Kovacs (1998), we cannot rule out the possibility that the 
improvement in performance was entirely due to carbohydrates or additional 
micronutrients found in the ED.  In this regard, even the 5 participants that arrived to the 
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lab with elevated blood caffeine levels improved time-trial performance by an average of 
3% when they received ED. Notably the magnitude of increase in blood caffeine was still 
significant in participants with high initial blood concentrations, though the absolute 
increase was reduced (379 to 2324 and 1842 to 3196 ng/ml for low-baseline and high-
baseline participants, respectively).  It is therefore unlikely that caffeine is the only 
ingredient responsible for the ergogenic effect of the ED since participants with elevated 
baseline caffeine levels improved performance. 
While we did not study ED against a carbohydrate-only control drink, there is 
evidence that caffeine in the ED was in part responsible for the ergogenic effect. Caffeine 
alone has been shown to lead to an uncoupling of exertion and perceived exertion. In an 
exercise protocol requiring participants to perform as much work as possible during 2 
hours of cycling, those who ingested caffeine had enhanced work performance with no 
difference in RPE (Ivy et al., 1979). Similarly, caffeine enhanced performance on an 8-
km running race without increasing RPE (Bridge & Jones, 2006). There are several 
possible explanations for the improved RPE induced by caffeine.  Caffeine is known to 
increase central neuronal excitability, reduce the threshold of neuron activation 
(Waldeck, 1973) as well as potentiate muscle contractile force directly (Tarnopolsky & 
Cupido, 2000).  Caffeine has been found to act as an adenosine receptor antagonist 
(Fredholm, Chen, Masino, & Vaugeois, 2005) and adenosine agonists have specifically 
been shown to induce fatigue in rats (Davis et al., 2003).  It also has been shown to 
increase circulating β-endorphin levels during exercise (Laurent, 2000). In the current 
study we did not see a significant effect of ED on β-endorphins, but we did observe 
improved exercise performance without a consequent increase in RPE.  Therefore, we 
propose that the uncoupling of RPE and true exertion we observed was the result of the 
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action of caffeine on the central nervous system, and its direct potentiating effect on 
muscle force production. 
Carbohydrates consumed within an hour of exercise onset have not always 
resulted in ergogenic effects (Foster et al., 1979), whereas caffeine consumption in this 
timeframe has consistently yielded exercise performance benefits (Graham & Spriet, 
1991; Ivy et al., 1979; Schneiker et al., 2006). The proposed mechanism by which 
carbohydrate feedings immediately before exercise may hinder performance is that an 
increase in insulin and blood glucose will down-regulate lipid oxidation and result in 
earlier depletion of carbohydrate energy stores (Foster et al., 1979). In the current study, 
we observed an increase in resting insulin concentrations and a subsequent fall in blood 
glucose at exercise onset, but only when participants received ED. The observed increase 
in VO2 without a significant shift in RER in the current study indicates that after 
consuming ED participants were metabolizing both carbohydrates and lipids at a faster 
rate during exercise without shifting the relative proportions: the lack of change in RER 
is in spite of the significant increase in catecholamines that we observed in this study. 
Caffeine has been shown to increase catecholamine levels in other exercise protocols 
(T.E. Graham & Spriet, 1991; T.E. Graham et al., 2000; Spriet et al., 1992). The addition 
of caffeine to a carbohydrate supplement taken shortly before exercise onset may counter 
any inhibitory effects of hyperglycemia and hyperinsulinemia by activating intramuscular 
triglyceride oxidation and sparing muscle glycogen (Essig et al., 1980). Research using 
muscle biopsies to detect changes in muscle triglyceride and glycogen concentration as 
well as tracers to determine rates of uptake of blood glucose and FFA are necessary to 
specifically determine the exact sources of energy used during exercise when athletes 
consume a complex energy drink. 
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In the current study we also examined the effects of ED on decision making and 
psychomotor performance before, during, and after exercise. Participants completed 
several tasks including a tapping test, a reaction time test, an executive function test 
(including aspects of both the tapping test and reaction time test), and a Stroop test. We 
demonstrated that consumption of ED will cause enhanced simple movement time as 
assessed by the tap test before and after intense exercise. The effect was not found in the 
executive function test. The heightened difficulty of the executive function test compared 
to the tap test is likely responsible for this discrepancy. During the executive function test 
participants tapped a button as fast as possible with 1 hand while the other hand was 
responsible for quickly moving to different locations based on a visual cue. Since 
participants garnered a benefit from ED on the tap test, but not on the same performance 
measure (taps per second) during the executive function test, we believe that simple 
psychomotor performance was aided by the ED but this beneficial effect is diminished 
during more complex bimanual tasks. The effect of the ED on tapping speed seems to be 
due to the caffeine content, since follow-up analysis revealed that only the participants 
who had low-baseline caffeine concentrations had significantly improved speed. 
The ED did not result in a change in decision making ability as assessed by the 
executive function or Stroop tests. Both caffeine and carbohydrate in isolation have 
beneficial effects on cognitive performance. Taken 40 minutes prior to a task, caffeine 
ingestion has improved movement time in volunteers (Durlach, 1998), while 
carbohydrate ingestion has been found to benefit memory (Benton & Owens, 1993). In 
the present study memory was not evaluated, so the effect of ED on this aspect of 
cognitive function cannot be assessed. A limitation of this work is that a ceiling effect 
was seen for both methods of evaluating decision making ability where most participants 
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completed the tasks with 100% accuracy. The consequences of the ceiling effect are 
compounded by the small sample size, and a type II error may have been made. 
The ED resulted in less precision during the tap test, though the loss of accuracy 
was not ecologically significant. ED did not result in differences on other cognitive 
measures. Since ED enhanced simple movement time without resulting in a clinically 
significant loss in accuracy, it may be beneficial for athletes to ingest prior to exercise to 
enhance psychomotor performance. 
A main effect for time was observed for reaction time indicating that regardless of 
treatment drink provided, exercise enhanced this aspect of psychomotor performance. 
Working extensively with soccer players, McMorris demonstrated that exercise itself 
enhances movement time. In a series of studies, soccer players had faster decision-
making time when exercising at high intensities on a cycle ergometer (McMorris, 1997), 
and that this improvement in decision-making time was paired with elevated levels of 
epinephrine (McMorris, 1999). The participants in the current study showed rising 
epinephrine levels as the time of exercise increased and subsequently had faster 
performance on the Stroop test. However, despite significant differences in plasma 
epinephrine levels between ED and PLA there were no differences in Stroop scores. 
Since this study demonstrated ergogenic properties of ED using a smaller caffeine 
dose than that which has been traditionally studied (Costill, Dalsky, & Fink, 1978; 
Graham & Spriet, 1995; Hulston & Jeukendrup, 2008; Ivy et al., 1979), we believe that 
further study into the synergistic effects of the ingredients is warranted. Specifically, 
utilizing alternative treatment drinks (carbohydrate-only, caffeine-only, micronutrient-
only) in addition to complete ED and PLA treatments in a protocol similar to ours will 
lend further insight into which ingredients are responsible for the ergogenic effects. 
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Additionally, dose-response studies will be useful to elucidate what the optimal ratio of 
the active ingredients is for athletic performance. 
Studies that examine the effectiveness of the product on longer and shorter 
duration events are also justified since caffeine has been shown to benefit exercisers in a 
2000-meter rowing event lasting approximately 6 minutes, in 1 study (Bruce et al., 2000), 
but not another (Skinner et al., 2010). Furthermore, ingestion of caffeine alone improved 
running performance over 30-40 minutes in an 8-km race (Bridge & Jones, 2006). The 
complex formula of ED may benefit athletes participating in events of shorter duration 
than we tested in this study. 
While the methods used to assess cognitive performance in the current study were 
chosen for ease of implementation and data acquisition, they did not provide ecological 
validity: the manner in which we evaluated reaction time required the movement of 
relatively small muscle groups (the fingers and forearms only), whereas whole-body 
reaction time is more relevant for most athletic events. In this regard, a positive effect of 
caffeine on whole-body reaction time has been demonstrated (Duvnjak-Zaknich, 
Dawson, Wallman, & Henry, 2011). The researchers found that caffeine in isolation 
enhanced the abilities of team-sports athletes to react to sports-specific stimuli before and 
after a simulated game. Future research may find an effect of ED on reaction time if it is 
assessed during movements that more mimic movement associated with various sports. 
A final set of future studies that can be developed from the current work involves 
examining the metabolic effects of ED in non-exercising conditions. Caffeine may alter 
insulin sensitivity, so tests of ED’s effects on glucose tolerance in healthy and insulin 
insensitive individuals are warranted. Furthermore, caffeine has been demonstrated to 
elevate resting metabolic rate in both athletes and non-athletes, so investigation into this 
product’s ability to alter basal metabolism is justified. 
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In conclusion, the ED resulted in improved cycling time-trial performance as well 
as improved performance on a simple psychomotor test. Participants who arrived to the 
laboratory with elevated basal caffeine levels benefitted on the time-trial race to the same 
extent as those who arrived with low basal caffeine levels, implying that the combination 
of caffeine and carbohydrates in the ED were responsible for the ergogenic effects. Only 
participants with low-baseline caffeine levels had improved tapping speeds due to ED, 
suggesting that caffeine specifically was the responsible ingredient for improving this 
aspect of psychomotor performance. However, the addition of other micronutrients may 
have also influenced our outcomes. Follow-up work utilizing carbohydrate-only and 
caffeine-only controls will shed light on the relative contributions and interactions of 





Pre-exercise nutritional supplementation is commonly practiced among endurance 
athletes in order to enhance physical and cognitive performance. Red Bull energy drinks when 
ingested one hour before a cycling time-trial ride lasting approximately 60 minutes were shown 
to improve race times by 3% (Ivy et al., 2009). In addition to enhancing athletic performance, 
energy drink consumption has been shown to improve reaction time and reduce reports of mental 
fatigue in a study of 80 adults aged 18-40 (Howard & Marczinski, 2010). 
There are a multitude of ingredients in energy drinks including caffeine, carbohydrate, 
carnitine, ginseng, glucuronolactone, grape seed extract, guaraná, inositol, milk thistle, and 
taurine (Babu, Church, & Lewander, 2008). The sugar content of energy drinks ranges from 0-47 
grams per 8 oz. serving while the caffeine content ranges from 24-640 mg (Heckman, Sherry, & 
Gonzalez de Mejia, 2010). For comparison, 8 oz. of unsweetened American coffee contains 76-
131 mg of caffeine and 0 grams of sugar (Santini et al., 2011). 
This literature review will systematically report the research related to exercise and 
cognitive performance effects of energy drink consumption. Aerobic exercise performance 
effects of the following energy drink ingredients will be analyzed: caffeine, carbohydrate, 
ginseng, glucuronolactone, guaraná, inositol, and taurine. The same ingredients will then be 
discussed in regards to their effects on cognitive performance. Since exercise itself impacts 
cognitive performance (McMorris, Sproule, Turner, & Hale, 2011), the interaction between 
exercise and cognition in the absence of nutritional supplementation will be examined next. 
Finally a conclusion about the effects of an energy drink on aerobic and cognitive performance 
during and after exercise will be made. 
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The Effects of Energy Drink Ingredients on Aerobic Performance 
CAFFEINE ENHANCES AEROBIC EXERCISE PERFORMANCE 
Caffeine has been studied for ergogenic potential since the early 20th century. 
Researchers quantified the amount of work performed in successive sets of resistance exercise on 
an ergograph (see Figure 1) by 2 individuals when they had received either caffeine or a placebo 
(Rivers & Webber, 1907). Other early work demonstrated that caffeine enhanced handgrip 
strength and endurance (Thornton et al., 1939) and restored work capacity after fatigue (Alles & 
Feigen, 1942) better than a placebo. These studies gave participants doses in the range of 1.4 to 
5.7 mg/kg. While the results were encouraging, there was a lack of statistical analysis to 
objectively evaluate the data. 
 
Figure 1 An ergograph. A participant lifts a weight via a pully. The lifting motion causes deflection of a pen which will trace a 
line with a  length that  is directly related to the amount of work performed. Work was quantified by this method  in early 
research (Alles & Feigen, 1942; Rivers & Webber, 1907). 
In the late 1970s and early 1980s there was resurgence in research on caffeine as a 
supplement for athletes. If given caffeinated coffee (providing 330 mg of caffeine) 60 minutes 
before exercising, cyclists rode 15 minutes longer at 80% of VO2max than if they were given 
decaffeinated coffee (Costill et al., 1978). If given decaffeinated coffee, the athletes in the study 
had higher ratings of perceived exertion (RPE) throughout the ride though there was no 
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difference in RPE at the time of fatigue. The RER was lower when subjects had consumed 
caffeine. FFA and glycerol were greatest when participants received caffeine at all times 
measured, though no statistically significant pairwise comparisons were reported. 
Caffeine in isolation has enhanced aerobic performance in a variety of exercise 
conditions. Over the course of a 2-hour cycling bout, exercisers performed more work and 
maintained a higher average VO2 compared to placebo without an increase in RPE if they were 
provided with 500 mg of caffeine in divided doses (Ivy et al., 1979). The benefits of taking 
caffeine are not limited to cycling performance since when given 9 mg/kg of caffeine 1 hour 
prior to exercise athletes had prolonged endurance at 85% of VO2max whether tested on a 
treadmill or cycle ergometer (Graham & Spriet, 1991). Even in lower doses caffeine prolonged 
running time to exhaustion at 85% of VO2max better than a placebo if provided as 3-9 mg/kg 1 
hour prior to exercise onset  (Graham & Spriet, 1995). Caffeine is ergogenic even in athletic 
events that are of shorter duration since runners performed an 8-km race 1.2% faster if they had 6 
mg/kg caffeine 1 hour before (Bridge & Jones, 2006). 
The ergogenic effects of caffeine are not limited to prolonged endurance activity as 
several studies have also shown benefits in exercise protocols that include a significant 
glycolytic component (Bruce et al., 2000; Schneiker et al., 2006; Wiles et al., 1992). Athletes 
completed a 1500-m race faster and with an increased VO2 and blood lactate concentration if 
they were provided with caffeine before the race (Wiles et al., 1992). Rowers finished a 2000-m 
race faster when they were provided 6 mg caffeine per kg body mass (Bruce et al., 2000). 
However in a study by Skinner (2010) this fining could not be replicated. Team sports athletes 
produced more power during intermittent sprints in both halves of a 72-minute exercise protocol 
when they had ingested caffeine before competition (Schneiker, Bishop, Dawson, & Hackett, 
2006b). Cyclists have been shown to complete more work in a 60-second cycling time-trial if 
they received 5 mg/kg of caffeine 1 hour before the time-trial (Wiles et al., 2006). 
Caffeine has ergogenic effects on aerobic performance whether the athlete is a habitual 
consumer of caffeine or not. Both habitual and non-habitual users of caffeine had improved 
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times to exhaustion at 80% of VO2max if given 5 mg/kg of caffeine 1-3 hours prior to exercise 
onset (Bell & McLellan, 2002). Two studies which were already discussed also showed that 
caffeine had ergogenic effects whether participants were regular consumers or not (T.E. Graham 
& Spriet, 1991; J.D. Wiles et al., 1992).  
It had been demonstrated that caffeine increased the blood FFA level (Bellet, Kershbaum, 
& Finck, 1968), and that a non-caffeine induced increase in circulating FFA led to subsequent 
increases in endurance performance (Costill et al., 1977). The observation that RER was lower 
and plasma FFA were higher during exercise following consumption of caffeine (Costill et al., 
1978; Ivy et al., 1979) led researchers to speculate that caffeine was ergogenic due to enhanced 
usage of lipids and a sparing of muscle glycogen. This was partially supported by Spriet et al. 
(1992) who found that ingestion of 9 mg/kg of caffeine 1 hour prior to exercise prolonged time 
to exhaustion at 80% of VO2max and spared muscle glycogen. Doses as low as 5 mg/kg have also 
been shown to reduce muscle glycogen depletion during moderate intensity exercise (Erickson et 




Figure  2  From  Essig  et  al.  (1980).  Caffeine  elevated  resting  blood  FFA  and  by  30 
minutes of exercise of moderate intensity.  
The support for the metabolic hypothesis is not unequivocal. Costill’s group reported 
differences in RER, plasma FFA, and blood glycerol during exercise performance after 
participants received caffeine (Costill et al., 1978; Essig et al., 1980; Ivy et al., 1979), but the 
differences were only statistically significant in two of the studies (Essig et al., 1980; Ivy et al., 
1979) (see Figure 2). The glycogen sparing effect of caffeine was paired with a lower RER and 
increase in FFA in the studies by Essig et al. (1980) and Ivy et al. (1979), but not in two other 
studies (Erickson et al., 1987; Spriet et al., 1992). Casal and Leon (1985) found that caffeinated 
coffee increased plasma FFA at rest but did not result in differences in VO2, or RER during 45 
minutes of running at 75% of VO2max compared to decaffeinated coffee or control, nor was there 
a treatment effect on post-exercise measures of blood FFA or glucose. If participants followed a 
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3-day carbohydrate loading protocol, there were no metabolic shifts (as indicated by blood FFA, 
blood glucose, VO2 and RER) due to 6.5 mg/kg of caffeine provided 3 hours before a 2-hour 
cycling bout at 75% VO2max (Weir et al., 1987). Utilizing a combination of arterial and venous 
blood samples and muscle biopsies from men exercising for 1 hour at 70% of VO2max, Graham et 
al. (2000) found that ingesting 6 mg/kg of caffeine had no effect on substrate utilization at the 
active muscle. However, the lipolytic effect of caffeine may require exercise to be in excess of 
60 minutes (Ivy et al., 1979). 
When caffeine and carbohydrate are supplemented together, exercise performance is 
enhanced, but lowered plasma FFA indicate the ergogenic effect is not entirely due to caffeine-
induced lipolysis (Ivy et al., 2009; Kovacs et al., 1998). Caffeine in the amount of 154-328 mg 
added to a 70 g carbohydrate and electrolyte solution (including 72 mg taurine) enhanced 
exercise performance greater than the carbohydrate electrolyte solution alone though plasma 
FFA were lower than when participants received a placebo (Kovacs et al., 1998) (see Figure 3). 
The exercise protocol used was a time-trial in which participants completed a set workload that 
was equivalent to exercising at 70% of VO2max at 90 rpm for one hour. Using the same exercise 
protocol, Red Bull energy drink (consisting of 160 mg of caffeine, 54 g of carbohydrate, 2 mg of 
taurine, and 1.2 g glucuronolactone) shortened the time to finish by 3% but FFA and glycerol 
were reduced (Ivy et al., 2009). Moreover, Hulston and Jeukendrup (2008) demonstrated no 
difference in RER, or rate of appearance, or disappearance of blood glucose between treatments 
when participants completed a time trial while consuming a 6.4% carbohydrate solution or the 




Figure  3  From  Kovacs  et  al.,  (1998).  CES=carbohydrate  electrolyte  solution.  150,  225,  320=  approximate  dose  in mg  of 
caffeine delivered in total. 
The exact physiological mechanism responsible for caffeine’s ability to enhance exercise 
performance is elusive. Caffeine may act ergogenically due to actions on the sympathetic 
nervous system (SNS) via the central nervous system (Graham et al., 2000). Epinephrine 
increases in the blood at rest and during exercise following 6 mg/kg of caffeine consumption 
(T.E. Graham & Spriet, 1991, 1995; Graham et al., 2000; Spriet et al., 1992). Red Bull energy 
drink also elevated epinephrine (Ivy et al., 2009). Additionally, RPE has remained unchanged 
from placebo though exercise performance has actually increased in several studies (Bridge & 
Jones, 2006; Costill et al., 1978; J.L. Ivy et al., 1979; J.D. Wiles et al., 1992) indicating that 
caffeine may have blunted central fatigue. This line of thought is supported by work in rodent 
models where it has been shown that caffeine’s primary physiological function in the central 
nervous system is as an adenosine antagonist, specifically binding A1 and A2A receptors which 
normally inhibit wakefulness and motor activity, respectively (Fredholm et al., 2005). 
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Furthermore, caffeine may reduce central fatigue by inducing the release of endogenous pain-
killers, β-endorphins. Laurent (2000) demonstrated that ingestion of 6 mg/kg of caffeine 90 
minutes before exercise led to increased plasma β-endorphins compared to placebo. The study by 
Ivy et al. (2009) described previously showed a tendency for β-endorphins to be elevated by the 
end of exercise when subjects were administered caffeine compared to placebo, though the 
difference was not statistically significant (p=0.10). 
A final explanation for caffeine’s ability to induce ergogenesis is modification of calcium 
handling within the sarcoplasm resulting in lowered threshold for excitation-contraction 
coupling. Specifically it has been shown that muscles in humans will contract with more force at 
submaximal stimulation frequencies after a dose of 500 mg of caffeine (Lopes et al., 1983). 
Doses of 6 mg/kg administered to habituated or non-habituated caffeine consumers also induced 
increased force production at submaximal frequency stimulations, though maximal voluntary 
contractions were unaltered (Tarnopolsky & Cupido, 2000). 
Caffeine has repeatedly been shown to enhance exercise performance in events requiring 
a significant amount of energy production from aerobic metabolism (Graham & Spriet, 1991; Ivy 
et al., 1979; Schneiker et al., 2006). The effects are mostly likely mediated through a 
combination of metabolic action (Costill et al., 1978), stimulation of the central nervous system 
and up-regulation of the SNS (Graham et al., 2000), or modification of intramuscular calcium 
handling resulting in a reduced threshold for neuromuscular action (Tarnopolsky & Cupido, 
2000). 
CARBOHYDRATE TYPE AND TIMING INFLUENCE EFFECTIVENESS OF CARBOHYDRATE AS AN 
ERGOGENIC AID 
Carbohydrate Fed During Exercise Enhances Performance 
Carbohydrate feedings of 120 grams of glucose polymer over the course of 2.5 hours of 
walking exercise (45% of VO2max) prolonged endurance by 11.5% (Ivy et al., 1983). Similarly, 
when athletes were fed carbohydrate during exercise at 70% of VO2max they had an elevated RER 
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and prolonged endurance without altering the rate at which muscle glycogen was utilized (Coyle 
et al., 1986). Another study showed that when athletes were fed carbohydrate during prolonged 
intermittent intensity exercise ranging between 45-75% of VO2max, endurance was improved and 
this was in part due to a sparing of muscle glycogen (Yaspelkis et al., 1993). 
More recently it was shown that adding amino acids or caffeine to a carbohydrate 
supplement fed during exercise enhanced performance greater than if fed carbohydrate alone 
(Hulston & Jeukendrup, 2008; Ivy et al., 2003). Cyclists rode on ergometers at varying 
intensities between 45-75% of VO2max for 3 hours before completing a ride to exhaustion at 85% 
of VO2max (Ivy et al., 2003). Athletes fed a 7.75% carbohydrate solution rode 7 minutes (55%) 
longer than if they received placebo, and the addition of 1.94% protein to the solution further 
increased ride time to exhaustion by another 7.2 minutes (56%). When participants consumed a 
drink containing 5.3 mg/kg body mass of caffeine in addition to 6.4% carbohydrate, they 
finished a time-trial race faster than if they consumed the carbohydrate alone (Hulston & 
Jeukendrup, 2008). Therefore, carbohydrate supplementation is very capable of working 
additively with other forms of ergogenic aids.  
Carbohydrate Fed Before Exercise Has Equivocal Effects on Aerobic Performance 
While carbohydrate feedings during exercise aid endurance performance, carbohydrate 
feedings before exercise have been demonstrated to inhibit (Foster et al., 1979), enhance (Kirwan 
et al., 1998; William M. Sherman et al., 1989), or have no effect on (Hargreaves et al., 1987; 
Kirwan et al., 1998) exercise performance depending on the type of carbohydrate provided and 
timing of ingestion. Participants benefitted from carbohydrate feeding when it was provided 4 
hours prior to exercise initiation (Sherman et al., 1989) or if provided within an hour of exercise 
when it had a low glycemic impact (Kirwan et al., 1998). High glycemic impact carbohydrate 
feedings in the hour leading up to exercise have produced either no effect on exercise 
performance (Hargreaves et al., 1987; Kirwan et al., 1998; Kovacs et al., 1998) or have resulted 
in earlier fatigue (Foster et al., 1979). Recently it has been demonstrated that when athletes are 
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fed a complete meal 3 hours prior to exercise, the ingestion of 2.5 g/kg body mass of 
carbohydrate in the hour before exercise had no effect on performance (Rollo & Williams, 2010). 
The consumption of carbohydrate in the hour leading up to exercise has been associated 
with a rebound hypoglycemia early in exercise due to the dual effects of insulin- and contraction-
stimulated glucose clearance (Foster et al., 1979). While hypoglycemia was noted in several 
studies when carbohydrate was ingested immediately prior to exercise (Foster et al., 1979; 
Hargreaves et al., 1987; Kirwan et al., 1998), blood sugar did not always fall under these 
circumstances (Rollo & Williams, 2010), and exercise performance was not always negatively 
impacted (Hargreaves et al., 1987; Kirwan et al., 1998; Kovacs et al., 1998). It is no longer 
recommended that athletes make an effort to avoid carbohydrate feedings before exercise unless 
it is known to cause them personal gastric upset (Jeukendrup & Killer, 2010). 
Conclusion on the Effects of Carbohydrate on Aerobic Exercise Performance 
Carbohydrate fed to athletes during aerobic exercise consistently resulted in improved 
aerobic performance (Coyle et al., 1986; Ivy et al., 1983; Ivy et al., 2003; Yaspelkis et al., 1993) 
and the addition of protein (Ivy et al., 2003) or caffeine (Hulston & Jeukendrup, 2008) enhanced 
performance further. While the early research indicated that consumption of carbohydrate in the 
hour leading into an exercise bout would cause a detriment in performance (Foster et al., 1979), 
if the carbohydrate source is in the form of a mixed meal it is not likely to hinder performance 
(Foster et al., 1979; Kirwan et al., 1998) and recent recommendations do not suggest avoiding 
carbohydrate before exercise (Jeukendrup & Killer, 2010). 
OTHER ENERGY DRINK INGREDIENTS LACK SUFFICIENT RESEARCH TO CONCLUDE 
ERGOGENIC PROPERTIES 
Ginseng 
Ginseng in isolation has not been evaluated as a possible ergogenic aid. One study has 
revealed that ginseng had differing effects on blood glucose at rest depending on if it was 
ingested with or without carbohydrate (Reay et al., 2006). At rest, doses of 200-400 mg of 
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ginseng reduced blood sugar for at least 2 hours compared to placebo. When the 200 mg of 
ginseng was combined with a 25 g bolus of glucose, blood sugar levels were no different than 
when the glucose bolus was ingested alone indicating that any hypoglycemic effects of ginseng 
are lost when it is consumed with carbohydrate. While it remains to be studied, the ingestion of 
ginseng alone may hinder aerobic performance by causing early depletion of blood sugar levels, 
though co-ingestion with carbohydrate may attenuate these effects. 
Glucuronolactone 
Glucuronolactone is an intermediate in the pentose phosphate pathway (PPP) that serves 
to generate NADPH, nucleic acids, and pentose sugars. Glucuronolactone is also generated 
endogenously and can be used by the liver to modify toxic substances through glucuronidation.  
A study examining glucuronolactone’s effects on exercise performance directly was 
conducted in rats (Tamura et al., 1968). The researchers gave the rats intraperitoneal (IP) 
injections of glucuronolactone or other intermediates of the PPP between bouts of exhaustive 
swimming. After a third bout of fatiguing swimming, the rats were sacrificed and the liver was 
tested for its ability to neutralize toxic substances. The rats given glucuronolactone had enhanced 
swimming times and the greatest amount of liver enzyme activity (o-aminophenylglucuronide 
synthesis and β-D-glucuronide glucuronohydrolase activity) compared to rats injected with other 
PPP intermediates or a saline control. Though these effects were promising, each IP injection 
was 100 mg/kg body mass, which is a larger amount than has been tested in humans via any 
route of delivery.  
Another study demonstrated a positive effect on exercise performance when 1200 mg 
glucuronolactone and 2000 mg taurine were added to a caffeine (160 mg) and carbohydrate (54 
g) beverage given to athletes while completing moderate intensity cycling exercise (Geiβ et al., 
1994). Athletes rode at 70% of VO2max for 60 minutes prior to completing a ramp protocol where 
workload was increased by 50 W every 3 minutes until work output fell by 10%. The treatment 
drinks were given 30 minutes into the submaximal ride and the drink containing all ingredients 
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(Red Bull energy drink) resulted in improved performance during the ramp test compared to if 
the drink was lacking in glucuronolactone and taurine. A similar ramp protocol was performed 
by the athletes 24 hours later with similar results; if the athletes consumed a drink with all 
ingredients during the first exercise protocol they had enhanced endurance compared to when 
they consumed a drink that lacked glucuronolactone and taurine. Counter to other research 
(Kovacs et al., 1998), this study (Geiβ et al., 1994) also demonstrated that a drink containing 
only carbohydrate resulted in enhanced endurance performance relative to a drink containing 
both caffeine and carbohydrate. 
Glucuronolactone has potential as an ergogenic aid but there is a lack of research 
examining the effects of this ingredient in isolation on human aerobic performance. 
Glucuronolactone may enhance exercise performance by preventing the buildup of toxic 
products of exercise through glucuronidation or by sparing liver glycogen from being diverted 
into the PPP for this purpose. 
Guaraná 
Guaraná is a seed extract that contains caffeine as well as other phytochemical 
components. Guaraná is primarily marketed as a thermogenic aid and as a weight-loss 
supplement. Guaraná has been studied as a thermogenic supplement but usually in combination 
with other ingredients (Bérubé-Parent et al., 2005; Haller et al., 2005; Sale et al., 2006) and 
rarely has it been studied in exercising humans (Sale et al., 2006). 
In combination with green tea extracts, guaraná increased 24-hour energy expenditure (by 
more than 150 Calories) while also elevating blood pressure (by 7 and 5 mmHg systolic and 
diastolic respectively) in healthy adults (Bérubé-Parent et al., 2005). These effects were likely 
due to the guaraná and not the green tea extract since several different doses of green tea were 
used with no difference in results. Unfortunately, the researchers did not report the exact amount 
of guaraná extract used, only that it was sufficient to produce 600 mg of caffeine over 3 doses 
per day. In addition to blood pressure, another study revealed that the effects of 250 mg of 
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guaraná extract and 325 mg of ephedra extract in overweight individuals at rest increased HR, 
postprandial glucose, postprandial insulin, and postprandial FFA (Haller et al., 2005). A third 
study examining the combined effects of guaraná, bitter orange, and green tea extract in a 
proprietary blend failed to demonstrate any metabolic shifts in obese men at rest or during 
moderate walking exercise at 60% of VO2max (Sale et al., 2006). The dose of guaraná delivered in 
this study was not explicitly stated, though it was less than 1262 mg. 
Guaraná has hypertension-inducing properties (Bérubé-Parent et al., 2005; Haller et al., 
2005). Caffeine is known to cause elevations in blood pressure (James & Gregg, 2004) and 
elevations in catecholamines (Papadelis et al., 2003), which could result in elevated blood 
pressure and HR. Since guaraná extract is always delivered in combination with caffeine, it is 
difficult to ascertain the unique contributions of guaraná to these physiological outcomes. 
Furthermore, the research in humans has always delivered guaraná with other dietary 
supplements (Bérubé-Parent et al., 2005; Haller et al., 2005; Sale et al., 2006), making 
conclusions about guaraná more convoluted. The ergogenic potential of guaraná may be limited 
to the ergogenic potential of caffeine. 
Inositol 
Inositol plays a role in various physiological functions. The focus of inositol 
supplementation research is as a therapeutic agent in various specialized populations including 
prenatal (Copp & Greene, 2010), neonatal (Hallman et al., 1992), individuals suffering from 
psoriasis due to lithium medication (O’Brien & Koo, 2006), and postmenopausal women with 
metabolic syndrome (Giordano et al., 2011). Apart from when inositol is an ingredient in energy 
drinks, there is a lack of research on the effects of inositol on athletic performance. 
Taurine 
Taurine is a nonessential amino acid that has been implicated in the proper functioning 
and maintenance of skeletal muscle (Pierno et al., 1998; Warskulat et al., 2004). Taurine may 
provide cardiovascular health benefits by reducing SNS activity: for a review see Abebe & 
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Mozaffari (2011). Elderly Wistar rats that ingested 1 g/kg of taurine daily for 2-3 months had 
greater intramuscular concentrations and improved responsiveness to electrical stimulation than 
unsupplemented controls (Pierno et al., 1998). If the transporter for taurine (taurine transporter 
system, taut) is not present due to gene knockout, rats have a reduction in treadmill exercise 
capacity of 80% or more demonstrating that taurine is normally a critical player in exercise 
performance (Warskulat et al., 2004). 
A study already highlighted in this review demonstrated an enhanced aerobic 
performance in athletes after consuming a Red Bull energy drink containing 2000 mg of taurine 
and 1200 mg of glucuronolactone compared to a similar drink lacking these two ingredients 
(Geiβ et al., 1994). The increase in exercise performance was also paired with significantly 
reduced blood concentrations of epinephrine and norepinephrine, which the author concluded 
were due to inhibitory action of taurine on the SNS. The conclusion is controversial since 
research on caffeine and exercise has routinely demonstrated an increase in epinephrine when 
performance is also enhanced (Graham & Spriet, 1991; Graham et al., 2000; Spriet et al., 1992), 
so a down-regulation of epinephrine would not be expected to necessarily lead to improved 
endurance. 
Unfortunately acute supplementation of taurine in humans has not been studied in 
isolation. At least two research papers cite a 1987 paper by M. Ono published in Sulfur Amino 
Acids titled “Effects of taurine on the metabolism under physical exercise” (Alford et al., 2001; 
Geiβ et al., 1994) but searches of Pubmed, Elsevier, and Googlescholar all failed to turn up a 
matching journal or article by this title. The studies on the effects of taurine on exercise 
performance have been performed in rats (Pierno et al., 1998; Warskulat et al., 2004) or when it 
is present with other ingredients (Geiβ et al., 1994). Taurine may act as an ergogenic aid, but the 
mechanism has not been sufficiently studied in humans. 
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Conclusion on the Effects of Other Ingredients on Aerobic Exercise Performance 
Aside from caffeine and carbohydrate, the ingredients often present in energy drinks do 
not have sufficient scientific evidence to support their use as ergogenic aids. Ginseng ingested 
without carbohydrate may be ergolytic if it induces hypoglycemia (Reay et al., 2006). 
Glucuronolactone delivered in high concentrations via IP injection revealed promising results in 
rats (Tamura et al., 1968), but follow-up research in humans is lacking. Guaraná has 
demonstrated metabolic effects that suggest an up-regulation of SNSA (Haller et al., 2005), 
which may translate into enhanced exercise performance comparable to what is seen with 
caffeine (Graham, 2001), but the studies are flawed in that guaraná is always delivered with 
caffeine and other ingredients. Inositol’s effects on exercise performance have not been tested. 
Taurine is a necessary component in young exercising muscle (Warskulat et al., 2004), but it has 
yet to be demonstrated that taurine supplementation will enhance exercise performance in 
humans. 
ENERGY DRINKS RELIABLY ENHANCE AEROBIC PERFORMANCE 
Compared to ingesting a placebo, participants that ingested a consumer-size serving of 
Red Bull energy drink (80 mg caffeine, 27 g carbohydrate, 600 mg glucuronolactone, 50 mg 
inositol, 1000 mg taurine) were able to exercise at a moderate workload (HR maintained between 
65-75% of HRmax) for a longer period of time (Alford et al., 2001). Other work used twice as 
much Red Bull but also demonstrated enhanced aerobic performance with a modest dose of 
caffeine (160 mg) compared to placebo (Ivy et al., 2009). Red Bull was also demonstrated to 
prolong endurance on a ramp protocol after participants completed 60 minutes of exercise at 
70% of VO2max (Geiβ et al., 1994). 
Traditionally, ergogenic doses of caffeine were at least 3 mg/kg of body mass (Costill et 
al., 1978; Graham & Spriet, 1995; Ivy et al., 1979; Schneiker et al., 2006). When combined with 
carbohydrate and taurine only (Kovacs et al., 1998) or as part of a more complex energy drink 
(Alford et al., 2001; Ivy et al., 2009) doses of only 80-160 mg have been effective. Conversely, 
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an energy patch delivering 74 mg of caffeine transdermally did not enhance performance 
compared to a placebo patch on repeated Wingate tests (Dragoo et al., 2011) indicating that the 
low dose of caffeine is not effective in the absence of carbohydrate. 
A proprietary blend of caffeine, glucuronolactone, and taurine as well as 40 kcal from 8 g 
of amino acids and sucralose was also demonstrated to enhance aerobic exercise performance as 
assessed by time to fatigue (Walsh et al., 2010). The total amount of caffeine, glucuronolactone 
and taurine in the powder (called Amino Impact) was 2.05 g though the authors did not specify 
the exact proportions of each component. Participants in the study ingested a serving of the 
energy drink powder dissolved in 500 ml of water 10 minutes prior to initiating exercise at 70% 
of VO2max. Though the supplement ingestion was placed closely to the time of exercise onset, a 
significant improvement in endurance was found. That participants only endured 21 minutes 
with the supplement or 13 minutes with the placebo indicates they were not well-trained athletes 
and raises questions as to the validity of the results.  
A placebo-controlled study found that the daily use of a low-calorie energy drink paired 
with an exercise program resulted in improved exercise adaptations in a group of previously 
sedentary men (Lockwood et al., 2010). The exercise program included 3 days of cycling and 2 
days of resistance training per week. Men in the study who received the energy drink made 
greater improvements in VO2max, body composition, and ventilatory threshold than men on the 
same training program who received a placebo. Furthermore, safety blood draws gathered over 
the ten weeks of the study showed that there was no compromised renal or hepatic function due 
to daily consumption of the energy drink. The energy drink in the study was called Celsius and 
contained a proprietary blend of caffeine, glucuronolactone, guaraná, taurine and other 
ingredients and contained only 10 kcal. 
Conclusion on Energy Drink Ingredients Effects on Aerobic Performance 
Caffeine in isolation reliably improves aerobic performance when consumed prior to 
exercise. Though carbohydrates before exercise have not always yielded ergogenic results, when 
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ingested with caffeine, performance has been improved. Based on the literature ingestion of an 
energy drink containing at least 80 mg of caffeine and 27 g of carbohydrate will improve aerobic 
performance if provided at least 30 minutes prior to exercise (Alford et al., 2001; Ivy et al., 
2009). In these studies glucuronolactone, inositol, and taurine were all provided as well. 
Glucuronolactone and taurine may improve the efficacy of caffeine and carbohydrate containing 
energy drinks (Geiβ et al., 1994) though the mechanisms of action are not understood. Ergogenic 
or ergolytic properties of ginseng, guaraná, and inositol have not been demonstrated. 
The Effects of Energy Drink Ingredients on Cognitive Performance 
CAFFEINE ENHANCES VARIOUS ASPECTS OF COGNITIVE FUNCTION 
Early work that examined caffeine’s effects on aerobic performance also reported that 
caffeine enhanced hand steadiness and tapping speeds in three subjects (Thornton et al., 1939). 
As noted before, this early work was flawed by modern standards for having a small sample size 
and was not statistically analyzed. 
Caffeine is well-known to attenuate cognitive deficits that are the resultant of sleep 
deficits. Participants kept awake for over 40 hours performed better on tests of psychomotor 
vigilance and choice reaction time over the subsequent 12 hours if provided with 600 mg of 
caffeine (Wesensten et al., 2002). Navy SEALs had improved visual vigilance and choice 
reaction time 1 and 8 hours after receiving 200-300 mg of caffeine when they had not slept in 72 
hours (Lieberman et al., 2002). Pilots in the US Air Force had better performance on a tracking 
task, short-term memory, and visual vigilance if they received 200 mg of caffeine every 4 hours 
during an overnight mission simulation (Doan et al., 2006). 
Caffeine also boosts aspects of cognitive function in individuals who are not specifically 
sleep-deprived. A study of 110 volunteers revealed that individuals who reported the greatest 
daily caffeine intake had the best maintenance of simple reaction time from the beginning to the 
end of their workdays (Smith, 2005). Individuals who were low to moderate consumers of 
caffeine improved response time and executive control of attention during a flankers task when 
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they ingested 100-400 mg of caffeine 30 minutes earlier (Brunyé et al., 2010). Individuals who 
regularly consumed high amounts of caffeine (greater than 550 mg per day) only benefitted if 
they were given 400 mg (Brunyé et al., 2010). 
In doses as low as 60 mg, caffeine improved pattern recognition when taken 10 minutes 
before the task, and movement time when taken 40 minutes before the test (Durlach, 1998). In 
this work the caffeine was consumed as hot tea mixed with 20 ml of part-skim milk, which 
contributed approximately 10 kcal and less than 1 g carbohydrate. Follow-up research by the 
same group demonstrated that reaction time was reduced within minutes of consuming the lose 
dose (Durlach et al., 2002). While average caffeine intake of participants in the first study was 
not reported (Durlach, 1998), in the second study participants all consumed greater than 200 mg 
of caffeine per day (Durlach et al., 2002). The rapid improvement in reaction time in this study 
may have been due to a reward response due to habitual consumption rather than a physiological 
effect of caffeine itself. 
An even smaller dose of caffeine, 12.5 mg, resulted in improvements in simple reaction 
time from 2-66 minutes regardless of whether the participant was a low or high consumer of 
caffeine (Smit & Rogers, 2000). Individuals who typically consumed large amounts of caffeine 
(207-532 mg/day) also had improvements in rapid visual information processing from 34-66 
minutes. In addition to improving simple reaction time, 1.2 mg/kg of caffeine also enhanced 
mood, focus of attention, and lowered perception of difficulty of cognitive tasks following 8 
hours of caffeine abstinence (Heatherley et al., 2005). 
One study demonstrated that the cognitive benefits of caffeine extend into athletic 
reaction time (Duvnjak-Zaknich et al., 2011). The researchers demonstrated that caffeine in 
isolation enhanced the abilities of team-sports athletes to react to sports-specific stimuli before 
and after a simulated game. Specifically a 6 mg/kg dose of caffeine resulted in improved reactive 
agility times assessed by how fast athletes would change directions and sprint through the correct 







Caffeine has effects on response time that precipitate within ten minutes of ingestion, 
even when provided in doses as low as 60 mg (Durlach, 1998; Durlach et al., 2002). If an 
individual has not had caffeine for at least 8 hours a dose of 1.2 mg/kg body mass improved 
mood, focus, and lowered perception of difficulty of cognitive tasks (Heatherley et al., 2005). 
When sleep-deprived, caffeine’s effects become pronounced as it enhances visual vigilance and 
response time (Lieberman et al., 2002; Wesensten et al., 2002). Caffeine has also been shown to 
improve whole body choice reaction time when athletes are physically fatigued after a team-
sports game simulation (Duvnjak-Zaknich et al., 2011). 
CARBOHYDRATE INGESTION IS ASSOCIATED WITH IMPROVED COGNITIVE PERFORMANCE 
Breakfast is often touted as the most important meal of the day. In children, overnight 
and early morning fasting resulted in a variety of inhibited cognitive processes, including 
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impaired memory and visual discrimination (Pollitt et al., 1998). In adults the skipping of 
breakfast also resulted in reduced memory though no effects were seen on intelligence quotient 
(Benton & Parker, 1998; Benton & Sargent, 1992). Regular feedings are likely necessary to 
maintain cognitive function as well. Reaction times were improved in physicians who were 
provided with balanced meals throughout their workdays compared to when they were not 
(Lemaire et al., 2010). 
Conversely, other work did not show a difference in performance on several cognitive 
measures after 48 hours of restricted carbohydrate intake: there was no difference in performance 
on tests of visual vigilance, choice reaction time, or reasoning between individuals fed a normal 
diet, a diet consisting of predominantly carbohydrate, or a diet only contributing ~20% of energy 
needs (H. R. Lieberman et al., 2008). The results from this study (H. R. Lieberman et al., 2008) 
seem to contradict those of other studies. Whereas other studies did not include a placebo group 
(Benton & Parker, 1998; Benton & Sargent, 1992), these researchers went so far as to create 
artificial foods that had comparable texture and taste to food that contributed more kcal. Further, 
this study is not directly comparable to those that use children as participants (Pollitt et al., 1998) 
since they are in a heightened state of metabolic demand due to growth. 
Supplementations of carbohydrate enhance cognitive performance during tasks requiring 
high energy expenditure. US Army Rangers were able to maintain vigilance by responding to 
auditory stimuli with less delay over the course of a 10-hour physically demanding day if 
provided with supplemental carbohydrate rations (Lieberman et al., 2002). The soldiers who 
received 12% carbohydrate solution performed better on the vigilance task than those who 
received 6% solution, though both groups were in an energy deficit during the study. Also, after 
completing a protocol designed to simulate a team-sports competition, athletes performed better 
on a whole-body motor-skills test when they had ingested 128 g of carbohydrate over the course 
of exercise (Welsh et al., 2002). 
Regardless of baseline blood glucose or absorptive state, when provided with 50 g or 
more of glucose memory has been found to be enhanced (Benton & Owens, 1993). In direct 
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contrast, an acute intake of 26 grams of carbohydrate in adults who were not fasted did not result 
in improved performance compared to energy-free placebo on measures of rapid visual 
information processing, reaction time, or memory in another study (Warburton et al., 2001). The 
apparent reason for the discrepancy in results is the carbohydrate provided: the lower amount of 
glucose provided in the second study may not have been sufficient to stimulate a cognitive 
enhancing effect. 
While the findings of at least one study indicate that a lack of sufficient carbohydrate will 
not lead to cognitive detriments (H. R. Lieberman et al., 2008), most research indicates that 
regular meals improve cognition in normal daily tasks (Benton & Parker, 1998; Lemaire et al., 
2010; Pollitt et al., 1998). During physically demanding tasks carbohydrate intake specifically 
has been demonstrated to help attenuate cognitive decline (Lieberman et al., 2002; Welsh et al., 
2002). 
OTHER ENERGY DRINK INGREDIENTS LACK SUFFICIENT RESEARCH TO CONCLUDE 
COGNITION-ENHANCING PROPERTIES 
Ginseng 
A study using acute doses of ginseng found conflicting results on its efficacy to improve 
cognitive performance (Andrew et al., 2002). Specifically, participants performed no different or 
worse than placebo on a serial-subtraction task when they received 200 or 600 mg of ginseng 
extract 1-2.5 or 6 hours prior to testing, though they performed better at 4-6 hours if they 
received a 400 mg dose. The results were limited to when participants performed a serial-
subtraction task using sevens, but there were no significant findings when the participants instead 
had to subtract by threes. More recent work by the same research group showed that acute 
administration of 200 mg of ginseng delayed the onset of negative mood in participants but it 
also resulted in delayed responses to mental arithmetic (Reay et al., 2010). 
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Ginseng paired with ginkgo biloba at “flavoring” concentrations did not result in 
differences in cognitive performance on simple reaction time, choice reaction time, word recall, 
or working memory (Scholey et al., 2004). Only 12.5 mg of ginseng was provided in this study. 
The research on panax ginseng in regards to cognitive function has been primarily 
focused on chronic supplementation on humans with cognitive deficits (Lee et al., 2008), or 
nonhumans (Petkov et al., 2003). The research demonstrating positive cognitive effects in 
healthy humans is inconsistent: see Lieberman (2001) for a review. 
Glucuronolactone 
Glucuronolactone is involved in glucuronidation of toxins in the liver and is normally 
produced in sufficient quantities via the PPP shunt (Eisenberg et al., 1959). One hour after taking 
600 mg glucuronolactone with 1000 mg of taurine and 80 mg of caffeine participants had better 
reaction time and attention during a stressful testing situation than when placebo was consumed 
(Seidl et al., 2000). Aside from this study, there is a lack of research on the effects of 
glucuronolactone on cognitive performance except when it is provided with other ingredients in 
an energy drink. 
Guaraná 
Participants receiving doses of 37.5 mg or 75 mg of guaraná extract (approximately 11% 
caffeine) 1 to 6 hours prior to cognitive testing had improvements in secondary memory 
compared to placebo, though no effects were seen for speed or accuracy of attention, speed of 
memory, or working memory (Haskell et al., 2007). Other research on the effectiveness of 
guaraná is limited in that guaraná is always co-administered with caffeine. 
Inositol 
Despite inositol’s various physiological functions, there is no research on its effects on 




As a stand-alone ingredient, chronic taurine supplementation as 1% of the total diet (0.94 
g/kg) was found to be ineffective at improving learning and memory in Wistar rats (Ito et al., 
2009). The rats in the study performed similarly to control rats in learning how to navigate a 
water maze. The research on taurine as a cognitive enhancing agent in humans is limited to 
investigations where it is combined with other ingredients in energy drinks. 
Conclusion on the Effects of Other Ingredients on Cognitive Performance 
Of the ingredients commonly added to energy drinks reviewed, only ginseng, guaraná, 
and taurine have research that evaluated effects on cognitive performance. The research is not 
convincing in that ginseng has produced mixed results (H. R. Lieberman, 2001), guaraná’s 
effects are likely due to inevitable co-administration with caffeine, and taurine was unable to 
enhance learning when tested in rats (Ito et al., 2009). 
ENERGY DRINKS ENHANCE COGNITIVE PERFORMANCE GREATER THAN CONSTITUENT 
INGREDIENTS 
When Red Bull energy drink was consumed 1 hour prior to testing, it enhanced attention 
and verbal reasoning compared to a carbohydrate-only control supplement or a placebo 
(Warburton et al., 2001). Notably, participants in this study were permitted to have caffeine ad 
libitum until the time of testing but still had performance enhancements due to the supplement. A 
double-dose of Red Bull (consisting of 160 mg of caffeine, 54 g of carbohydrate, 2 mg of 
taurine, and 1.2 g glucuronolactone) reduced lane drifting and enhanced reaction time during 2 
hours of simulated driving compared to a control drink (Horne & Reyner, 2001). A smaller dose 
of Red Bull given to participants prior to 4 hours of driving also reduced lane drifting and 
variations in vehicle speed (Mets et al., 2011). A dose-response study of Red Bull revealed that 
the greatest improvements on a go/no-go task were seen with a dose of 1.8 ml/kg body mass with 
improvements being reduced at higher dosages (Howard & Marczinski, 2010). A dose of 1.8 
ml/kg would only result in 126 ml for a 70 kg person, which is slightly more than half of the 
dose provided in a commercial volume of the beverage (Warburton et al., 2001) and 
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approximately one quarter of the dose provided in other studies (Horne & Reyner, 2001; Ivy et 
al., 2009). 
An energy drink containing 75 mg caffeine, 37.5 g glucose, and 12.5 mg ginseng given to 
participants 30 minutes prior to cognitive testing resulted in enhancements in secondary memory 
and speed of attention (Scholey & Kennedy, 2004). In this study participants receiving the 
caffeine or glucose in isolation did not perform better on any cognitive measure tested compared 
to placebo. This lead the investigators to conclude that the ingredients worked synergistically. 
When participants received 75 g glucose or 75 g caffeine they had enhanced simple reaction 
time, but when the ingredients were consumed together participants also had improved learning 
and consolidation of verbal memory (Adan & Serra-Grabulosa, 2010).  
It has been shown that a combination of caffeine and carbohydrate can enhance both 
physical and cognitive performance during glycogen-depleting exercise (Hogervorst et al., 
2008). The participants ingested either 100 mg of caffeine with 45 g of carbohydrate as a bar, the 
bar without caffeine, or a placebo drink immediately before starting a 2.5 hour ride at 60% of 
VO2max. During the ride participants received two more boluses of the treatment. At the end of 
the ride participants completed a ride to exhaustion at 75% of VO2max. Additionally participants 
completed cognitive testing twice during the 2.5 hour ride and once after the ride to exhaustion. 
The results of the study showed that when participants received the full supplement their aerobic 
performance (time to exhaustion) and reaction time during the cognitive tests were better than 
when they received the other two supplements The bar containing carbohydrate only resulted in 
improvements over the placebo beverage on both measures, as well. 
Conclusion on Energy Drink Ingredients Effects on Cognitive Performance 
Caffeine enhances cognitive performance in individuals who are sleep-deprived 
(Lieberman et al., 2002) and in doses as low as 60 mg in rested individuals (Durlach et al., 
2002). Caffeine and carbohydrate appear to have a synergistic effect on cognitive performance 
(Adan & Serra-Grabulosa, 2010; Kennedy & Scholey, 2004), even during and after a prolonged 
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moderate-intensity exercise (Hogervorst et al., 2008). The addition of glucuronolactone and 
taurine may further enhance the cognitive effects of caffeine and carbohydrate mixtures, as Red 
Bull energy drink has been shown to enhance cognitive performance (Horne & Reyner, 2001; 
Howard & Marczinski, 2010; Mets et al., 2011; Warburton et al., 2001). 
Aerobic Exercise Enhances Reaction Time without a Detriment to other 
Cognitive Processes 
Prolonged endurance exercise does not appear to impair cognitive performance. 
Prolonged low-intensity walking activity had no effect on performance of simple psychomotor 
tasks (Ivy et al., 1983). Runners performed to the same level on a Stroop color-word test before 
and after completing either a 30-km race or a marathon (Blomstrand et al., 1991). 
Enhancements in cognitive performance due to exercise have been observed when tested 
under sport-specific settings. For example, McMorris and Graydon (1997) presented soccer 
players with visual images of game or non-game situations where a soccer ball was or was not 
present. The images were presented for only two seconds and the participants’ task was to 
respond with a “yes” if a ball was present or a “no” if a ball was not present. The primary 
findings from the study were that when players were exercising at maximum intensity on a cycle 
ergometer they had improved speed of decision without a loss of accuracy, though the results 
were equivocal when the exercise was at 70% VO2max. When the researchers made the task more 
complex by instructing participants to make a decision to pass, shoot, dribble, or run, maximal 
intensity exercise also increased accuracy of decision making compared to when participants 
were at rest. The authors concluded that the maximum exercise intensity invoked a greater 
release of catecholamines that were responsible for the improvement in decision-making time. 
Follow-up work by the same researchers tested soccer players using the same testing 
protocol but examined performance when participants were at rest, exercising at the “adrenaline 
threshold”, or exercising at VO2max (McMorris et al., 1999). The “adrenaline threshold” was 
determined as the point at which blood epinephrine increased above baseline values during an 
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incremental exercise test (see Figure 5). Similar to their previous work, researchers found that 
decision making time was enhanced when participants were exercising at their maximal aerobic 
capacity. The researchers also found that speed of decision making was enhanced at the 
“adrenaline threshold” although this corresponded to a lower workload than their previous work 
(56% of VO2max compared to 70%). 
 
Figure  5  From  T. McMorris  et  al.  (1999).  "Adrenaline  threshold" was  defined  as  the  point  at which  blood  epinephrine 
concentrations increase disproportionately to increased workload during an incremental exercise test. 
In order to make the cognitive tasks more ecologically valid, the researchers modified the 
protocol so that correct reactions included passing a ball to a target in front of the athlete instead 
of simply verbalizing a cognitive decision as in previous iterations of the research (McMorris et 
al., 2000). No differences in reaction time or accuracy of decision-making were seen due to the 
exercise at any intensity compared to rest. The explanation for the loss in an exercise effect on 
cognitive performance may be due to study design: in previous versions of the research the 
players verbalized cognitive decisions while cycling on an ergometer (McMorris et al., 1999; 
McMorris & Graydon, 1997), while in this study the participants rode on a cycle ergometer until 
reaching the necessary exercise intensity but dismounted the ergometer and were no longer 
exercising when the cognitive decision was made.  
To make the exercise condition more similar to what is actually experienced by soccer 
players, the investigators tested the effects of repeated sprints on passing frequency and accuracy 
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(McMorris & Rayment, 2007). The researchers saw a linear decrease in passing accuracy, an 
inverted-U shaped response in passing frequency, and a linear increase in both HR and RPE as 
athletes went from resting to three consecutive 100-meter sprints (see Figure 6). 
 
Figure 6 From Terry McMorris & Rayment  (2007). The  researchers  found an  increase  in gross motor  skill performance as 
passing errors increased from rest to three sprints of 100‐m. The number of passes increased after one sprint, but returned 
to resting levels after three. HR and RPE both increased with higher levels of exercise. 
Another study was conducted to assess the effects that aerobic exercise had on tests 
designed to measure executive function and memory (Coles & Tomporowski, 2008). 
Researchers found no benefit of completing 40 minutes of low-moderate intensity exercise (10 
minutes of 30% VO2max and 30 minutes of 60% VO2max) on measures of executive function as 
determined by a set-switching task and a Brown-Peterson test, or in overall memory as 
determined by word recall tasks. The researchers did report that there was an improvement due 
to exercise in recalling words in the primacy and recency portions of the word lists that 
participants were presented with. 
It has been demonstrated that during exercise individuals become more acutely sensitive 
to visual cues while performance on executive function tasks remain unchanged (Lambourne et 
al., 2010). Participants exercised on a cycle ergometer for 40 minutes at 90% of ventilatory 
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threshold (VT) and at 5 times during the workout completed a critical flicker fusion (CFF) test 
and paced auditory serial addition task (PASAT). Performance on the CFF increased as the 
exercise time increased and was significantly different than a resting control by 35 and 40 
minutes of exercise. 
Another study demonstrated an improvement in responses to visual stimuli during 
exercise (Sanabria et al., 2011). Participants performed better on a test of exogenous spatial 
attention when exercising for 20 minutes at 85% of their anaerobic threshold compared to 
performing the same test while at rest. The participants also performed better on the test 
immediately after exercise compared to resting performance. 
The effects of acute bouts of exercise on cognitive processes are mixed. Exercise 
enhances speed of reaction (McMorris et al., 1999; McMorris & Graydon, 1997; McMorris et al., 
2011) as well as simple sensitivity to visual stimuli (Lambourne, Audiffren, & Tomporowski, 
2010b; Sanabria et al., 2011), though complex motor skill performance may be hindered 
(McMorris et al., 2011) and executive function does not appear to be affected (Coles & 
Tomporowski, 2008; Lambourne, Audiffren, & Tomporowski, 2010b). Prolonged aerobic 
exercise leading to dehydration will lead to cognitive deficits though shorter bouts may have 
positive effects on cognitive processes (Tomporowski, 2003). 
Conclusion 
The combination of caffeine and carbohydrate has been demonstrated to enhance both 
aerobic and cognitive performance when ingested immediately prior to and throughout glycogen 
depleting exercise (Hogervorst et al., 2008). It has not been shown if the addition of other energy 
drink components will result in further enhancements during this type of exercise. Nor has it 
been shown if similar effects can be observed during or after an exercise that is of shorter 
duration and higher intensity (e.g., a one-hour time-trial cycling race). Finally, given that many 
athletic events are structured in a manner that make continued supplementation during 
competition difficult to achieve, it is worthwhile to evaluate the effectiveness of enhancing 
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aerobic and cognitive performance when an energy drink is delivered in the hour prior to 
exercise. 
Red Bull energy drink (containing caffeine, carbohydrate, glucuronolactone, and taurine) 
has been proven effective in enhancing aerobic performance (Alford et al., 2001; Ivy et al., 2009) 
as well as cognitive performance (Horne & Reyner, 2001; Howard & Marczinski, 2010; Mets et 
al., 2011; Warburton et al., 2001). Ginseng’s effects on cognition are unclear, but are likely to be 
nonnegative (H. R. Lieberman, 2001) while it has not been studied as an ergogenic aid. Guaraná 
has been shown to enhance secondary memory in one study (Haskell et al., 2007), though 
comprehensive research on its effects on cognition or exercise is lacking. Similarly, there is no 
research on inositol’s unique effects on exercise or cognitive performance. 
When taken prior to a 1-hour bout of moderate- to high-intensity exercise, an energy 
drink containing caffeine, carbohydrate, ginseng, glucuronolactone, guaraná, inositol, and taurine 
will likely serve as an ergogenic aid while also enhancing cognitive performance.
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APPENDIX A: DESCRIPTIVE AND INFERENTIAL STATISTICS 
Table 1: Participant Characteristics 
 
Females (N=7) Males (N=8) Total (N=15) 
X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ 
Age (yr.) 30 2.3 31 2.5 31 1.6 
Mass (kg) 65.7 2.50 69.7 3.68 67.8 2.27 
Height (cm) 171 1.8 177 2.7 174 1.7 
VO2MAX (mL/min) 3407 88.3 4251 201.1 3857 158.1 
IQ 122 3.8 112 4.5 117 3.2 
 
Table 2: Time to Finish (seconds) 
(N=15) X̄ SEX̄ 
ED 3848.5* 78.12 
PLA 3968.9 80.56 
*Effect found for treatment (p<.05).
 





& RER (CO2/VO2) 
X̄ SEX̄ X̄ SEX̄ 
5-7 km 
ED 2.9A 0.15 0.97A 0.008 
PLA 2.8A 0.17 0.96A 0.015 
16-18 km 
ED 2.8B 0.14 0.93B 0.010 
PLA 2.6B 0.14 0.92B 0.012 
28-30 km 
ED 2.8B 0.13 0.93B 0.011 
PLA 2.6B 0.11 0.91B 0.012 
&Main effect found for treatment (p<.001). 






Table 4: Heart Rate 
Time 
(N=9)^ 
Treatment& X̄ SEX̄ 
Pre Drink Pre Race 
ED 58 2.3 
PLA 60 2.7 
Post Drink Pre Race 
ED 58 2.6 
PLA 56 2.5 
1 km 
ED 153 4.4 
PLA 150 4.9 
6 km 
ED 165 3.2 
PLA 162 4.3 
12 km 
ED 172 3.4 
PLA 167 4.6 
17 km 
ED 166 3.2 
PLA 163 3.9 
23 km 
ED 169 3.0 
PLA 162 3.9 
29 km 
ED 169 2.4 
PLA 160 2.6 
34 km 
ED 171 3.2 
PLA 165 2.4 
Start of Stroop 
ED 167 3.6 
PLA 163 3.8 
30 seconds of Stroop 
ED 163 3.1 
PLA 157 3.3 
60 seconds of Stroop 
ED 161 3.2 
PLA 160 2.2 
90 seconds of Stroop 
ED 163 2.7 
PLA 161 2.5 
120 seconds of Stroop 
ED 163 2.8 
PLA 161 2.6 
^HR was not recorded for 5 participants at all 14 times, resulting in N=9 for RM ANOVA.
&Main effect for treatment was found (p<.05). 





Table 5: RPE (Borg 6-20) 
Time 
(N=15) 
Treatment X̄ SEX̄ 
1 kmA 
ED 12 0.5 
PLA 12 0.5 
6 kmB 
ED 14 0.3 
PLA 14 0.4 
12 kmCF 
ED 16 0.3 
PLA 15 0.4 
17 kmD 
ED 15 0.4 
PLA 15 0.4 
23 kmEF 
ED 16 0.4 
PLA 16 0.5 
29 kmCEF 
ED 16 0.4 
PLA 16 0.5 
34 kmG 
ED 17 0.4 
PLA 17 0.4 
























ED 5.8A 0.18 535 18.7 347A 24.4 881 41.0 





ED 5.9A 0.21 522 20.0 336AB 24.2 858 33.0 
PLA 5.4A 0.18 558 23.0 345AB 25.6 903 42.2 
Post 
Race 
ED 6.2B 0.18 507 21.3 319BC 22.7 826 35.9 
PLA 5.9B 0.18 542 32.0 336BC 28.2 878 52.5 
&Main effect were found for treatment (p<.05). 
A-CMain effects found for time with and LSD post-hocs revealed differences between times 
(p<.05). 
 
Table 7: Tap Test 
Time Treatment 
Percent of Precise Responses& 
(N=11)^ 
Taps Per Second 
X̄ SEX̄ X̄ SEX̄ 
Pre Drink Pre Race 
ED 99.8 0.08 3.7 0.13 
PLA 99.8 0.15 3.7 0.11 
Post Drink Pre Race 
ED 99.5 0.22 3.7* 0.12 
PLA 99.6 0.10 3.4 0.09 
Post Race 
ED 99.2 0.41 3.9* 0.09 
PLA 99.6 0.25 3.8 0.11 
^Precision data was not recorded for four participants at all six times, resulting in N=11 for RM 
ANOVA. 
*Interaction found and LSD post-hocs revealed differences between treatments at the times 
indicated (p<.05). 

























X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ 
Pre Drink 
Pre Race 
ED 92.4 3.30 1.18 0.088 98.5 0.69 1.10A 0.071 95.9 1.26 1.14A 0.070 
PLA 90.8 6.64 1.12 0.117 98.0 0.91 1.11A 0.062 97.6 0.99 1.14A 0.070 
Post Race 
ED 92.6 2.84 1.09 0.064 96.8 1.30 0.99B 0.061 95.3 1.26 1.03B 0.058 
PLA 92.3 4.84 1.07 0.069 96.1 1.46 1.03B 0.051 94.9 1.81 1.04B 0.058 






























ED 35.3 6.66 63.7 6.49 425 19.4 374A 31.1 799 26.6 





ED 41.4 7.59 58.2 7.56 397 14.4 350B 33.0 747 31.6 
PLA 42.4 6.75 56.1 6.76 434 17.7 349B 32.8 783 32.9 
Post 
Race 
ED 42.3 6.27 55.7 6.60 407 16.7 327C 32.5 734 30.1 
PLA 41.2 6.80 57.1 6.73 446 31.4 324C 30.1 770 49.9 




















X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ 
Pre Drink 
Pre Race 
ED 27 3.3 83 1.5 0.29 0.032 0.05A 0.006 0.7 0.05 18ABCDE 2.6 
PLA 26 2.0 83 1.4 0.25 0.020 0.05 A 0.006 0.7 0.03 19ABCDE 3.6 
Post Drink 
Pre Race 
ED 63* 5.9 82 5.5 0.13* 0.014 0.04A 0.003 1.7* 0.08 19ABD 3.3 
PLA 27 3.0 77 1.5 0.21 0.020 0.06 A 0.008 0.7 0.03 18ABD 4.0 
6 km 
ED 26 2.5 63* 3.5 0.10* 0.013 0.13B 0.016 4.8* 0.38 17AC 3.3 
PLA 22 2.4 79 2.0 0.19 0.019 0.16B 0.023 3.5 0.49 17AC 3.8 
17 km 
ED 20 1.3 76* 2.6 0.14* 0.021 0.26C 0.030 4.8* 0.48   
PLA 23 2.5 85 1.7 0.26 0.029 0.27C 0.038 3.1 0.50   
23 km 
ED 20 1.6 76* 2.3 0.17* 0.028 0.31D 0.037 4.3* 0.47 19ABDE 4.4 
PLA 21 1.5 82 1.9 0.27 0.027 0.30D 0.040 2.6 0.38 20ABDE 4.5 
29 km 
ED 18 1.2 74 2.1 0.22 0.042 0.35E 0.042 4.1* 0.34 20ABDE 3.3 
PLA 18 1.9 75 2.2 0.28 0.036 0.33E 0.045 2.4 0.34 21ABDE 4.9 
34 km 
ED 19 2.5 70 2.6 0.24 0.049 0.38F 0.045 4.1* 0.38 22ADE 4.3 
PLA 19 2.5 74 2.1 0.30 0.039 0.36F 0.046 2.6 0.44 21ADE 4.0 
*Interactions found and LSD post-hocs revealed differences between treatments at the times indicated (p<.05). 






















X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ 
Pre Drink 
Pre Race 
ED 886 226.6 76 16.6 394 36.0 0.04A 0.004 28ABC 2.4 
PLA 614 180.6 58 12.6 379 56.2 0.04A 0.004 28ABC 2.9 
Post Drink 
Pre Race 
ED 2416* 208.5 60 16.1 685 84.0 0.03B 0.003 27AB 1.9 
PLA 604 177.3 46 10.0 763 108.8 0.06B 0.021 26AB 2.8 
6 km 
ED         28AB 2.5 
PLA         25AB 2.5 
17 km 
ED   482* 29.7 2849* 308.7   31AC 3.0 
PLA   235 19.7 2239 246.8   29AC 2.2 
23 km 
ED         34D 3.0 
PLA         32D 2.8 
29 km 
ED   507* 46.2 2766 294.7   35D 3.0 
PLA   263 21.8 2229 247.8   31D 2.6 
34 km 
ED 2615* 216.0 628* 73.1 2789 313.2 0.06C 0.007 35D 2.6 
PLA 557 172.0 349 66.7 2420 276.1 0.06C 0.008 31D 2.5 
^Blood sample was hemolysed for one participant at one time, resulting in N=14 for RM ANOVA on β-Endorphins assay: no 
interaction or main effects were seen with α=.05 on this assay unless the value was removed. 
*Interactions found and LSD post-hocs revealed differences between treatments at the times indicated (p<.05). 




Table 12: Time to Finish- With Groups Split by Baseline Caffeine Levels (seconds)
 
Pooled (N=15) Low-Baseline (N=10) High-Baseline (N=5) 
X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ 
ED 3848.5* 78.12 3842.9* 89.19 3869.3* 137.53 
PLA 3968.9 80.56 3965.8 100.43 3988.0 123.84 
*Effect found for treatment (p<.05). 
 
Table 13: Blood Caffeine- With Groups Split by Baseline Caffeine Levels (ng/mL) 
Time Treatment 
Pooled (N=15) Low-Baseline (N=10) High-Baseline (N=5) 
X̄ SEX̄ X̄ SEX̄ X̄ SEX̄ 
Pre Drink Pre Race 
ED 886 226.6 379 157.2 1842 266.9 
PLA 614 180.6 178 72.7 1486 183.5 
Post Drink Pre Race 
ED 2416* 208.5 2081* 236.5 3087* 190.5 
PLA 604 177.3 148 37.9 1516 108.6 
34 km 
ED 2615* 216.0 2324* 245.2 3196* 304 
PLA 557 172.0 127 41.5 1418 159.2 




Table 14: Tap Test- With Groups Split by Baseline Caffeine Levels 
Time Treatment 
Pooled (N=15) Low-Baseline (N=10) High-Baseline (N=5) 
X̄ SEX̄ X̄ X̄ SEX̄ X̄ 
Pre Drink Pre Race 
ED 3.7 0.13 3.7 0.10 3.6 0.31 
PLA 3.7 0.11 3.7 0.09 3.6 0.26 
Post Drink Pre Race 
ED 3.7* 0.12 3.8* 0.09 3.8 0.29 
PLA 3.4 0.09 3.4 0.10 3.4 0.17 
Post Race 
ED 3.9* 0.09 4.0 0.11 4.0 0.19 
PLA 3.8 0.11 3.8 0.14 3.7 0.19 
*Interaction found and LSD post-hocs revealed differences between treatments at the times indicated (p<.05).
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APPENDIX B: RAW DATA 
Table 7: Participant Characteristics 
Participant Age Gender Mass (kg) Height(cm) VO2max(mL/min) IQ 
F1 25 F 57.6 165.1 3160 126
F3 27 F 71.9 175.26 3270 109
F4 32 F 62.8 165.1 3650 121
F5 41 F 65.5 175.26 3430 136
F6 33 F 63.2 170.18 3170 109
F8 24 F 77.1 175.26 3770 126
F9 27 F 62 175.26 3400 128
M1 43 M 58 165.1 3610 113
M2 29 M 66.8 172.72 4690 111
M3 24 M 60.4 172.72 3470 123
M4 32 M 69.9 177.8 4260 114
M7 26 M 92 185.42 5180 94 
M8 29 M 73 182.88 4620 96 
M9 41 M 66 170.18 4080 133




Table 16: Time to Finish (seconds) 
Participant ED PLA 
F1 4294.52 4338.18 
F3 4409.25 4464.51 
F4 3933.56 4089.37 
F5 3863.28 3905.52 
F6 4027.61 4301.93 
F8 3917.7 4053.71 
F9 3716.15 3878.34 
M1 3882.18 3976.56 
M2 3461.67 3528.71 
M3 4171.5 4356.93 
M4 3851.34 3930.06 
M7 3372.42 3542.76 
M8 3423.78 3432.42 
M9 3719.34 3872.19 




Table 8: Gas Collection 
Participant 
VO2 (L/min) RER (CO2/VO2) 
5-7 km 16-18 km 28-30 km 5-7 km 16-18 km 28-30 km 
ED PLA ED PLA ED PLA ED PLA ED PLA ED PLA 
F1 2.30 2.34 2.24 2.21 1.95 2.06 0.91 0.86 0.82 0.97 0.92 0.92 
F3 2.52 2.24 2.01 2.02 2.24 2.05 0.97 0.86 0.89 0.82 0.81 0.80 
F4 2.89 2.54 3.00 2.64 2.93 2.63 0.93 0.95 0.94 0.90 0.91 0.89 
F5 2.64 2.73 2.40 2.54 2.44 2.47 0.97 0.92 0.91 0.92 0.89 0.88 
F6 2.34 2.23 2.44 2.23 2.38 2.52 0.97 0.98 0.95 0.91 0.92 0.98 
F8 2.83 2.71 2.70 2.51 2.59 2.30 0.95 0.93 0.92 0.96 0.90 0.89 
F9 2.82 2.50 2.63 2.32 2.65 2.37 0.97 0.91 0.9 0.91 0.87 0.87 
M1 2.68 2.81 2.57 2.39 2.70 2.45 0.93 0.91 0.91 0.94 0.90 0.91 
M2 4.22 4.13 3.82 3.51 3.60 3.39 0.98 0.97 0.94 1.05 0.97 0.93 
M3 2.48 2.29 2.50 2.03 2.49 2.28 1.01 0.94 0.93 0.97 0.96 0.96 
M4 2.83 2.67 2.49 2.55 2.85 2.51 0.98 0.91 1.00 1.00 0.97 0.93 
M7 4.09 4.06 3.78 3.71 3.89 2.95 0.98 0.97 0.97 1.00 0.97 0.92 
M8 3.72 3.67 3.50 3.40 3.36 3.35 0.97 0.94 0.91 0.95 0.91 0.90 
M9 2.78 2.46 2.58 2.46 2.58 2.19 1.03 0.98 0.98 1.02 1.00 0.99 











End of Visit 
ED PLA ED PLA ED PLA 
F1 62 63 55 57 65 71 
F3 56 59 66 48 62 62 
F4 50 61 62 39 84 68 
F5 47 47 49 42 63 59 
F6 57 57 61 55 70 73 
F8 63 64 72 52 77 68 
F9 55 59 54 57 65 74 
M1 59 51 58 48 ^ 70 
M2 55 56 59 57 80 80 
M3 70 75 62 62 87 92 
M4 57 62 58 58 86 85 
M7 52 55 54 51 91 82 
M8 49 46 46 41 83 87 
M9 54 57 50 56 78 76 
M10 67 66 63 68 99 85 




Table 10: Heart Rate (beats per minute) 1 km to 12 km During the 
Race 
Participant 
1 km 6 km 12 km 
ED PLA ED PLA ED PLA 
F1 151 146 168 166 172 157 
F3 153 152 159 144 ^ 153 
F4 134 126 157 147 173 158 
F5 129 ^ 148 140 149 147 
F6 144 127 163 149 170 152 
F8 163 156 175 170 184 181 
F9 152 144 166 157 163 156 
M1 126 110 142 142 148 137 
M2 167 151 178 175 176 174 
M3 135 132 147 145 155 142 
M4 149 164 159 155 157 155 
M7 165 167 172 173 181 178 
M8 163 159 170 166 171 172 
M9 160 135 160 147 177 165 
M10 133 158 163 177 179 180 




Table 20: Heart Rate (beats per minute) 17 km to 34 km During the Race 
Participant 
17 km 23 km 29 km 34 km 
ED PLA ED PLA ED PLA ED PLA 
F1 168 166 169 160 160 160 178 159 
F3 141 137 145 135 147 137 145 150 
F4 167 166 173 138 177 ^ 180 132 
F5 140 141 145 148 143 137 153 143 
F6 168 159 167 160 168 167 166 164 
F8 179 169 178 172 174 156 178 160 
F9 160 149 161 149 161 151 168 ^ 
M1 146 132 143 143 149 137 160 149 
M2 178 169 174 166 175 165 176 171 
M3 155 140 156 144 154 150 154 161 
M4 151 160 152 146 165 163 159 159 
M7 172 176 175 170 178 156 179 173 
M8 168 166 171 170 166 164 171 168 
M9 163 150 174 153 165 148 177 155 
M10 160 174 172 175 172 170 181 176 





Table 11: Heart Rate (beats per minute) During the Stroop Test After the Race 
Participant 
Start 30 seconds 60 seconds 90 seconds 120 seconds 
ED PLA ED PLA ED ED ED PLA ED PLA 
F1 170 157 1364 164 164 160 164 161 162 162 
F3 129 130 133 138 139 135 137 137 132 137 
F4 180 ^ 171 ^ ^ ^ 153 130 144 130 
F5 147 135 137 130 136 130 130 132 132 133 
F6 163 151 158 146 161 154 161 157 164 154 
F8 161 150 168 143 166 156 165 158 164 156 
F9 168 ^ 156 ^ 147 ^ 142 ^ 142 ^ 
M1 141 ^ 136 ^ 137 ^ 137 ^ 135 ^ 
M2 159 169 157 160 157 157 161 159 156 159 
M3 159 164 154 160 150 160 149 155 148 150 
M4 160 158 155 152 154 157 155 159 161 160 
M7 189 186 181 176 173 174 173 173 174 174 
M8 176 172 165 161 164 162 165 162 158 162 
M9 160 160 155 154 149 154 160 152 164 161 
M10 177 158 172 162 176 167 175 173 174 172 




Table 12: RPE (Borg 6-20) 
Participant 
1 km 6 km 12 km 17 km 23 km 29 km 34 km 
ED PLA ED PLA ED PLA ED PLA ED PLA ED PLA ED PLA 
F1 12 12 14 13 15 15 15 15 16 16 15 15 17 17 
F3 11 10 13 14 15 15 14 15 15 17 15 15 16 16 
F4 7 7 12 13 14 13 13 13 15 14 14 13 14 15 
F5 12 12 13 13 15 14 13 13 14 15 13 13 16 15 
F6 12 11 15 14 17 15 17 16 17 17 16 17 18 17 
F8 13 12 15 14 16 16 16 15 16 17 16 16 17 17 
F9 13 13 13 14 15 14 13 14 14 13 14 14 17 16 
M1 13 13 15 15 16 16 16 15 15 17 17 17 17 17 
M2 14 13 16 15 17 16 17 16 17 15 17 17 18 18 
M3 13 14 14 14 15 15 15 15 16 16 16 17 17 17 
M4 10 12 13 14 15 14 15 15 15 15 15 15 15 15 
M7 13 14 15 15 17 17 17 17 19 18 17 15 19 19 
M8 12 13 13 15 16 17 14 15 17 18 16 18 17 19 
M9 12 13 14 14 15 15 14 15 16 16 15 16 17 16 





Table 13: Executive Function Taps per Second 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA 
F1 5.4 5.1 5.3 5.1 5.9 5.4 
F3 4.6 4.9 5.1 4.8 5.1 4.6 
F4 4.9 4.8 4.7 4.7 5.4 5.6 
F5 5.5 4.0 4.4 5.0 5.4 5.2 
F6 6.1 6.1 6.2 4.7 6.2 6.5 
F8 6.5 6.1 6.8 5.9 7.2 6.4 
F9 4.6 4.6 4.9 4.2 5.0 4.6 
M1 5.9 5.5 6.2 5.4 6.3 5.9 
M2 6.3 6.0 6.1 6.1 6.9 6.8 
M3 6.6 6.9 7.0 6.6 6.2 5.9 
M4 5.5 5.6 5.9 5.6 6.2 6.0 
M7 6.7 6.5 6.9 6.3 7.1 6.7 
M8 6.3 5.7 6.1 5.6 6.7 6.1 
M9 6.3 5.8 6.3 5.8 6.4 6.1 





Table 14: Executive Function Reaction Time (milliseconds) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA 
F1 560 534 685 565 570 590 
F3 482 407 425 446 509 466 
F4 621 515 594 528 486 427 
F5 506 643 544 412 426 451 
F6 499 602 504 550 567 530 
F8 472 451 459 493 459 565 
F9 627 827 561 509 693 887 
M1 646 598 499 538 570 616 
M2 606 675 766 627 478 685 
M3 504 525 604 648 622 590 
M4 636 571 546 514 452 463 
M7 473 533 473 413 429 474 
M8 447 484 541 409 401 403 
M9 481 465 530 613 436 522 




Table 15: Executive Function Movement Time (milliseconds) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA 
F1 301 358 344 378 316 340 
F3 256 248 230 241 220 199 
F4 439 447 469 468 348 426 
F5 373 429 370 325 374 344 
F6 332 344 307 291 328 305 
F8 234 224 235 223 189 231 
F9 468 501 433 458 376 465 
M1 550 542 481 491 483 545 
M2 449 473 453 496 478 494 
M3 308 279 278 307 297 279 
M4 346 387 376 385 347 377 
M7 339 330 333 352 290 359 
M8 259 222 232 224 217 211 
M9 221 160 190 213 220 204 





Table 16: Executive Function Total Time (milliseconds) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA 
F1 861 892 909 1063 887 930 
F3 738 655 676 665 729 665 
F4 1060 962 997 1062 835 853 
F5 879 1072 783 869 800 794 
F6 831 946 857 795 894 835 
F8 705 676 729 682 648 796 
F9 1095 1328 942 1019 1069 1352 
M1 1196 1140 1019 991 1053 1161 
M2 1055 1149 1081 1262 956 1179 
M3 812 804 926 910 918 869 
M4 982 958 890 931 799 840 
M7 812 863 746 825 719 833 
M8 705 706 640 765 618 614 
M9 702 624 803 743 656 726 




Table 17: Tap Test Percent of Precise Responses 
Participant 
Pre Drink Pre Race Post Drink Pre Race Post Race 
ED PLA ED PLA ED PLA 
F1 99.6 99.7 99.6 99.6 99.7 100.0 
F3 ^ ^ ^ ^ ^ ^ 
F4 ^ ^ ^ ^ ^ ^ 
F5 99.3 100.0 100.0 99.6 100.0 100.0 
F6 100.0 100.0 100.0 100.0 100.0 100.0 
F8 100.0 98.3 97.5 99.6 95.7 97.4 
F9 99.6 100.0 99.6 99.4 100.0 99.6 
M1 ^ ^ ^ ^ ^ ^ 
M2 ^ ^ ^ ^ ^ ^ 
M3 100.0 100.0 99.7 100.0 99.7 100.0 
M4 99.7 100.0 99.7 99.6 100.0 100.0 
M7 100.0 100.0 99.0 99.0 97.6 98.4 
M8 100.0 100.0 100.0 100.0 99.7 100.0 
M9 100.0 100.0 100.0 100.0 100.0 100.0 
M10 100.0 100.0 99.2 99.2 99.3 99.6 





Table 18: Tap Test Taps per Second 
Participant 
Pre Drink Pre Race Post Drink Pre Race Post Race 
ED PLA ED PLA ED PLA 
F1 3.5 3.6 3.4 3.2 3.5 3.5 
F3 3.4 3.3^ 3.6 3.1 3.4 3.2 
F4 2.3 2.5 2.6 2.8 3.6 3.2 
F5 3.7 3.8 3.5 3.4 3.7 3.8 
F6 3.9 3.8 3.8 3.6 4.0 4.1 
F8 4.0 4.2 4.3 3.4 4.7 4.3 
F9 3.0 3.1 3.3 2.9 3.5 3.1 
M1 3.5 3.4 3.7 3.1 4.2 3.5 
M2 3.9 3.8 3.7 3.2 4.0 4.4 
M3 4.1 3.9 4.0 3.9 3.8 3.6 
M4 3.6 3.7 3.8 3.7 4.0 3.8 
M7 4.1 4.1 4.5 4.0 4.1 3.6 
M8 4.0 3.7 4.0 3.7 4.3 4.3 
M9 4.4 3.9 4.3 3.5 4.3 4.2 
M10 3.8 3.7 3.8 3.3 4.0 3.8 





Table 19: Stroop Test "Read" Stimuli 
Participant 
Percent of Correct Responses Reaction Time (seconds) 
Pre Drink Pre Race Post Race 
Pre Drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA ED PLA 
F1 100.0 100.0 85.7 100.0 0.90 0.92 0.77 0.94 
F3 100.0 100.0 100.0 100.0 1.11 0.96 1.05 0.80 
F4 60.0 0.0 90.9 28.6 2.11 0.00 1.50 1.12 
F5 91.7 100.0 100.0 100.0 1.17 1.20 1.39 1.25 
F6 100.0 100.0 100.0 100.0 0.91 1.03 0.91 0.89 
F8 100.0 100.0 100.0 100.0 0.89 0.88 0.89 0.77 
F9 100.0 100.0 100.0 100.0 1.01 0.96 1.09 1.03 
M1 66.7 100.0 90.0 100.0 1.23 1.94 1.33 1.39 
M2 100.0 100.0 100.0 100.0 1.40 1.50 1.30 1.25 
M3 100.0 100.0 88.9 100.0 0.89 0.96 0.86 0.87 
M4 90.9 100.0 100.0 100.0 1.72 1.52 1.21 1.47 
M7 100.0 85.7 92.3 90.0 1.13 1.66 1.44 1.60 
M8 100.0 100.0 100.0 100.0 1.19 1.14 0.96 1.08 
M9 90.9 92.9 60.0 80.0 0.94 0.82 0.84 0.80 





Table 20: Stroop Test "Incongruent" Stimuli 
Participant 
Percent of Correct Responses Reaction Time (seconds) 
Pre Drink Pre Race Post Race 
Pre Drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA ED PLA 
F1 100.0 100.0 100.0 100.0 0.76 0.85 0.77 0.85 
F3 95.2 100.0 85.0 88.9 0.96 0.96 0.81 0.94 
F4 100.0 95.7 100.0 100.0 1.01 1.15 0.92 1.05 
F5 100.0 100.0 100.0 100.0 1.13 1.31 1.33 1.23 
F6 100.0 100.0 100.0 100.0 1.09 1.21 1.06 1.09 
F8 95.5 100.0 90.5 95.7 0.95 0.90 0.88 0.75 
F9 96.0 100.0 100.0 100.0 0.99 0.92 0.90 0.90 
M1 100.0 91.7 92.3 100.0 1.84 1.40 1.51 1.32 
M2 100.0 100.0 100.0 94.7 1.37 1.26 1.28 1.13 
M3 100.0 100.0 90.0 100.0 0.77 0.83 0.82 0.85 
M4 100.0 100.0 100.0 100.0 1.41 1.54 1.18 1.36 
M7 95.5 100.0 100.0 92.9 1.01 1.50 1.05 1.30 
M8 100.0 100.0 100.0 94.1 1.22 1.01 0.87 0.92 
M9 100.0 93.3 100.0 95.0 0.95 0.88 0.78 0.80 





Table 21: Stroop Test Total (Both Stimuli Types) 
Participant 
Percent of Correct Responses Reaction Time (seconds) 
Pre Drink Pre Race Post Race Pre Drink Pre Race Post Race 
ED PLA ED PLA ED PLA ED PLA 
F1 100.0 100.0 96.8 100.0 0.81 0.87 0.77 0.87 
F3 96.4 100.0 89.7 92.9 0.99 0.96 0.88 0.89 
F4 81.8 91.7 96.2 77.3 1.51 1.10 1.16 1.07 
F5 96.2 100.0 100.0 100.0 1.15 1.29 1.35 1.24 
F6 100.0 100.0 100.0 100.0 1.05 1.16 1.01 0.99 
F8 96.4 100.0 93.1 96.8 0.94 0.89 0.88 0.76 
F9 96.4 100.0 100.0 100.0 0.99 0.93 0.93 0.91 
M1 90.0 95.2 91.3 100.0 1.66 1.63 1.43 1.35 
M2 100.0 100.0 100.0 96.2 1.38 1.37 1.29 1.16 
M3 100.0 100.0 89.7 100.0 0.78 0.86 0.83 0.86 
M4 95.5 100.0 100.0 100.0 1.56 1.53 1.19 1.41 
M7 96.4 95.5 96.0 91.7 1.04 1.55 1.25 1.42 
M8 100.0 100.0 100.0 96.4 1.20 1.06 0.89 0.98 
M9 96.4 93.1 86.2 90.0 0.94 0.85 0.80 0.80 





Table 22: Reaction Time Test Percent Outer Rim Responses 
Participant 
Pre Drink Pre 
Race 
Post drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA 
F1 18.8 18.8 43.8 37.5 56.3 25.0 
F3 62.5 81.3 75.0 68.8 43.8 87.5 
F4 23.1 15.4 0.0 0.0 15.4 0.0 
F5 68.8 50.0 81.3 25.0 68.8 43.8 
F6 25.0 25.0 41.7 66.7 25.0 33.3 
F8 66.7 53.3 73.3 60.0 66.7 93.3 
F9 12.5 25.0 31.3 31.3 56.3 18.8 
M1 40.0 20.0 0.0 26.7 13.3 26.7 
M2 0.0 0.0 9.1 0.0 9.1 9.1 
M3 56.3 43.8 56.3 50.0 43.8 50.0 
M4 0.0 26.7 6.7 13.3 13.3 26.7 
M7 12.5 31.3 31.3 56.3 37.5 56.3 
M8 27.3 27.3 54.6 45.5 54.6 45.5 
M9 78.6 92.9 85.7 85.7 92.9 64.3 





Table 23: Reaction Time Test Percent Correct and Precise 
Participant 
Pre Drink Pre 
Race 
Post drink Pre 
Race 
Post Race 
ED PLA ED PLA ED PLA 
F1 81.3 81.3 56.3 62.5 43.8 68.8 
F3 37.5 18.8 25.0 31.3 43.8 12.5 
F4 76.9 76.9 100.0 100.0 84.6 100.0 
F5 31.3 50.0 18.8 75.0 31.3 56.3 
F6 75.0 66.7 58.3 33.3 75.0 66.7 
F8 33.3 46.7 26.7 33.3 33.3 6.7 
F9 87.5 75.0 62.5 68.8 43.8 75.0 
M1 53.3 80.0 100.0 73.3 86.7 73.3 
M2 90.9 100.0 90.9 100.0 90.9 90.9 
M3 43.8 56.3 43.8 50.0 56.3 50.0 
M4 100.0 73.3 93.3 80.0 86.7 66.7 
M7 87.5 68.8 68.8 43.8 62.5 43.8 
M8 72.7 72.7 45.5 45.5 27.3 54.6 
M9 21.4 7.1 14.3 14.3 7.1 28.6 





Table 24: Reaction Time Test Reaction Time when Correct (milliseconds) 
Participant 
Pre Drink Pre Race Post drink Pre Race Post Race 
ED PLA ED PLA ED PLA 
F1 356 392 380 486 333 362 
F3 449 376 461 423 504 413 
F4 463 385 420 361 423 453 
F5 447 384 334 414 373 381 
F6 460 524 391 411 377 613 
F8 425 304 373 409 350 351 
F9 325 389 390 470 347 330 
M1 585 516 475 601 507 423 
M2 341 344 396 349 387 773 
M3 527 534 507 500 528 571 
M4 356 358 325 490 354 312 
M7 344 378 327 327 364 460 
M8 471 340 356 408 413 401 
M9 458 576 454 440 466 422 





Table 25: Reaction Time Test Movement Time when Correct (milliseconds) 
Participant 
Pre Drink Pre Race Post drink Pre Race Post Race 
ED PLA ED PLA ED PLA 
F1 318 358 302 337 283 338 
F3 279 209 237 213 232 187 
F4 508 580 503 568 474 480 
F5 330 338 333 344 329 302 
F6 347 330 298 294 310 303 
F8 248 234 226 186 190 190 
F9 501 477 376 411 422 448 
M1 355 340 406 383 316 328 
M2 544 633 612 590 558 552 
M3 256 270 237 237 210 220 
M4 595 548 520 460 466 393 
M7 470 476 462 446 403 429 
M8 319 289 234 268 132 234 
M9 192 165 174 192 175 167 




Table 26: Reaction Time Test Total Time when Correct (milliseconds) 
Participant 
Pre Drink Pre Race Post drink Pre Race Post Race 
ED PLA ED PLA ED PLA 
F1 673 750 682 823 616 699 
F3 728 584 698 636 736 600 
F4 972 966 923 928 898 932 
F5 777 722 667 758 702 683 
F6 807 854 689 705 687 916 
F8 673 538 599 595 540 541 
F9 826 866 766 880 770 778 
M1 940 856 881 984 823 750 
M2 885 976 1008 939 945 1325 
M3 782 804 744 738 738 790 
M4 951 906 845 950 820 705 
M7 815 854 789 772 766 889 
M8 789 629 589 675 545 635 
M9 650 741 628 632 641 589 





Table 27: Insulin (µU/mL) Start to 17 km 
Participant 
Pre Drink Pre Race Post Drink Pre Race 6 km 17 km 
ED PLA ED PLA ED PLA ED PLA 
F1 63 31 120 61 22 36 24 51 
F3 26 39 53 38 33 23 31 27 
F4 21 35 49 25 20 22 16 31 
F5 17 14 39 16 16 15 14 22 
F6 23 29 48 27 20 19 17 23 
F8 21 24 78 14 37 44 24 21 
F9 15 11 38 14 12 13 17 13 
M1 21 23 58 20 46 16 26 19 
M2 28 21 55 25 25 16 19 14 
M3 44 35 85 33 28 33 24 32 
M4 17 22 82 27 15 13 16 14 
M7 31 25 80 27 42 22 25 24 
M8 24 27 41 26 22 21 16 21 
M9 36 28 67 29 23 26 22 19 





Table 28: Insulin (µU/mL) 23 km to 34 km 
Participant 
23 km 29 km 34 km 
ED PLA ED PLA ED PLA 
F1 33 31 20 27 48 49 
F3 28 29 21 27 26 28 
F4 25 26 19 18 13 18 
F5 13 16 15 12 14 11 
F6 22 16 15 12 15 16^ 
F8 16 16 24 18 19 14 
F9 11 13 11 8 6 10 
M1 22 22 19 15 17 15 
M2 24 16 20 11 21 21 
M3 23 26 21 28 19 24 
M4 11 18 16 11 11 14 
M7 24 28 27 22 18 20 
M8 20 18 17 26 17 19 
M9 17 19 21 27 28 18 
M10 16 15 10 15 17 9 





Table 29: Glucose (mg/dL) Start to 17 km 
Participant 
Pre Drink Pre Race Post Drink Pre Race 6 km 17 km 
ED PLA ED PLA ED PLA ED PLA 
F1 77 87 68 78 62 91 77 98 
F3 85 78 66 77 63 79 81 84 
F4 77 85 72 74 63 78 88 86 
F5 82 83 46 77 54 80 80 87 
F6 80 85 66 79 69 75 88 79 
F8 83 70 97 64 87 78 80 90 
F9 80 84 95 83 62 84 65 82 
M1 93 86 123 82 81 84 67 84 
M2 91 87 95 85 83 87 86 94 
M3 91 92 60 82 67 82 85 85 
M4 88 83 95 79 42 74 63 83 
M7 80 80 95 77 61 92 86 95 
M8 82 78 88 65 52 62 69 75 
M9 82 89 58 79 40 76 69 82 





Table 40: Glucose (mg/dL) 23 km to 34 km 
Participant 
23 km 29 km 34 km 
ED PLA ED PLA ED PLA 
F1 80 93 76 86 65 84 
F3 79 76 83 74 77 76 
F4 90 89 91 77 88 69 
F5 70 80 69 81 60 77 
F6 84 79 85 64 83 75^ 
F8 86 76 71 68 75 79 
F9 69 82 68 80 65 79 
M1 69 87 72 73 73 70 
M2 81 79 71 71 67 64 
M3 87 88 86 89 86 84 
M4 66 82 63 82 69 84 
M7 83 93 72 77 64 73 
M8 70 74 70 71 60 67 
M9 64 81 69 82 65 75 
M10 65 67 64 58 54 56 





Table 30: Free Fatty Acids  (mmol/L) Start to 17 km 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
6 km 17 km 
ED PLA ED PLA ED PLA ED PLA 
F1 0.42 0.32 0.21 0.33 0.18 0.20 0.32 0.33 
F3 0.43 0.28 0.13 0.32 0.09 0.43 0.25 0.53 
F4 0.31 0.27 0.11 0.26 0.09 0.16 0.10 0.30 
F5 0.28 0.18 0.17 0.20 0.15 0.18 0.15 0.23 
F6 0.13 0.26 0.09 0.18 0.05 0.16 0.07 0.19 
F8 0.31 0.16 0.15 0.10 0.13 0.18 0.28 0.39 
F9 0.25 0.34 0.09 0.19 0.08 0.17 0.11 0.20 
M1 0.52 0.32 0.15 0.23 0.13 0.25 0.11 0.40 
M2 0.36 0.28 0.12 0.26 0.08 0.13 0.06 0.11 
M3 0.20 0.15 0.12 0.18 0.19 0.19 0.14 0.23 
M4 0.24 0.24 0.05 0.16 0.02 0.13 0.08 0.14 
M7 0.34 0.19 0.16 0.16 0.10 0.16 0.10 0.20 
M8 0.29 0.40 0.22 0.34 0.14 0.19 0.16 0.23 
M9 0.05 0.12 0.05 0.12 0.08 0.19 0.07 0.13 





Table 31: Free Fatty Acids (mmol/L) 23 km to 34 km 
Participant 
23 km 29 km 34 km 
ED PLA ED PLA ED PLA 
F1 0.44 0.30 0.67 0.29 0.66 0.30 
F3 0.29 0.53 0.42 0.50 0.54 0.63 
F4 0.12 0.29 0.13 0.24 0.12 0.26 
F5 0.14 0.21 0.16 0.29 0.20 0.35 
F6 0.09 0.20 0.09 0.17 0.08 0.22^ 
F8 0.34 0.38 0.41 0.64 0.57 0.54 
F9 0.13 0.21 0.23 0.21 0.14 0.24 
M1 0.21 0.35 0.16 0.32 0.27 0.38 
M2 0.14 0.10 0.13 0.12 0.12 0.10 
M3 0.15 0.29 0.18 0.20 0.21 0.19 
M4 0.10 0.22 0.13 0.15 0.12 0.18 
M7 0.14 0.20 0.12 0.24 0.16 0.24 
M8 0.19 0.27 0.20 0.19 0.24 0.22 
M9 0.05 0.13 0.11 0.21 0.13 0.14 
M10 0.07 0.33 0.10 0.37 0.10 0.47 






Table 32: Glycerol (mmol/L) Start to 17 km 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
6 km 17 km 
ED PLA ED PLA ED PLA ED PLA 
F1 0.06 0.05 0.06 0.07 0.13 0.20 0.39 0.21 
F3 0.01 0.03 0.04 0.07 0.13 0.32 0.32 0.51 
F4 0.10 0.07 0.06 0.08 0.26 0.20 0.47 0.38 
F5 0.05 0.04 0.04 0.07 0.10 0.17 0.22 0.31 
F6 0.02 0.04 0.02 0.03 0.06 0.09 0.11 0.17 
F8 0.05 0.03 0.05 0.02 0.15 0.12 0.28 0.28 
F9 0.08 0.09 0.05 0.09 0.23 0.31 0.45 0.57 
M1 0.07 0.04 0.04 0.03 0.13 0.12 0.21 0.25 
M2 0.08 0.06 0.04 0.09 0.14 0.12 0.27 0.20 
M3 0.04 0.02 0.04 0.03 0.09 0.08 0.17 0.12 
M4 0.04 0.02 0.04 0.04 0.10 0.10 0.18 0.18 
M7 0.05 0.03 0.02 0.03 0.09 0.09 0.18 0.16 
M8 0.05 0.11 0.07 0.13 0.20 0.27 0.30 0.43 
M9 0.01 0.02 0.03 0.02 0.06 0.03 0.11 0.06 





Table 33: Glycerol (mmol/L) 23 km to 34 km 
Participant 
23 km 29 km 34 km 
ED PLA ED PLA ED PLA 
F1 0.46 0.21 0.54 0.23 0.55 0.28 
F3 0.38 0.53 0.46 0.59 0.48 0.61 
F4 0.56 0.44 0.66 0.46 0.70 0.50 
F5 0.29 0.32 0.33 0.37 0.35 0.40 
F6 0.14 0.21 0.16 0.22 0.18 0.27^ 
F8 0.37 0.31 0.43 0.36 0.49 0.41 
F9 0.57 0.65 0.61 0.72 0.68 0.74 
M1 0.23 0.28 0.29 0.28 0.32 0.28 
M2 0.32 0.25 0.33 0.26 0.38 0.30 
M3 0.18 0.12 0.20 0.14 0.21 0.14 
M4 0.21 0.21 0.25 0.24 0.28 0.26 
M7 0.23 0.19 0.26 0.21 0.27 0.22 
M8 0.37 0.44 0.38 0.46 0.41 0.54 
M9 0.11 0.07 0.14 0.07 0.13 0.08 
M10 0.19 0.29 0.20 0.35 0.23 0.40 
^Blood draw missed but data point estimated using method 





Table 34: Lactate (mmol/L) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
6 km 17 km 
ED PLA ED PLA ED PLA ED PLA 
F1 0.7 0.9 1.7 0.9 2.8 3.2 2.6 2.5 
F3 0.7 0.7 1.4 0.6 2.6 0.8 1.7 0.8 
F4 0.6 0.7 1.9 0.7 4.8 3.4 6.0 3.1 
F5 0.7 0.7 1.7 0.8 4.6 2.6 4.4 2.5 
F6 0.8 0.6 2.0 0.8 3.9 1.5 5.3 1.8 
F8 0.8 0.8 1.6 0.6 5.9 3.5 4.6 2.7 
F9 0.7 0.6 1.7 0.6 6.4 2.5 5.2 1.5 
M1 0.7 0.6 2.2 0.7 4.3 2.7 3.5 1.2 
M2 0.6 0.7 1.4 0.7 8.0 6.9 9.3 8.7 
M3 0.9 0.8 1.7 0.8 3.5 2.9 4.9 2.6 
M4 0.8 0.7 2.0 0.8 4.3 1.9 3.4 3.2 
M7 0.5 0.6 1.2 0.5 6.7 7.8 7.5 5.4 
M8 1.3 0.8 1.7 0.9 4.5 4.8 3.6 4.2 
M9 0.8 0.8 1.7 0.7 5.1 3.0 4.6 2.5 





Table 35: Lactate (mmol/L) 23 km to 34 km 
Participant 
23 km 29 km 34 km 
ED PLA ED PLA ED PLA 
F1 2.7 2.2 2.2 2.0 2.5 2.8 
F3 1.4 0.7 1.5 0.8 1.2 0.9 
F4 5.4 3.8 5.0 2.8 6.3 2.9 
F5 4.1 2.2 3.5 2.4 3.4 1.9 
F6 4.6 1.5 4.3 2.3 4.9 2.37^ 
F8 4.2 2.2 4.2 1.4 3.7 1.8 
F9 5.0 1.5 4.1 1.3 4.5 1.5 
M1 2.6 2.3 3.5 1.4 3.7 1.1 
M2 8.6 7.2 7.0 6.1 6.9 7.0 
M3 5.4 2.0 4.5 4.5 5.4 6.0 
M4 2.5 1.9 4.7 2.6 4.2 3.1 
M7 6.5 3.4 5.0 1.9 4.7 1.9 
M8 2.8 2.9 2.6 2.7 2.4 2.3 
M9 3.5 2.1 4.2 1.7 3.4 1.5 
M10 5.1 2.3 4.6 1.8 4.6 1.4 






Table 36: Myoglobin (ng/mL) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
6 km 23 km 29 km 34 km 
ED PLA ED PLA ED PLA ED PLA ED PLA ED PLA 
F1 11 12 9 9 9 6 13 6 9 13 12 13 
F3 16 7 16 8 12 8 12 7 15 7 14 6 
F4 15 18 12 15 9 17 10 17 16 16 24 18 
F5 15 12 15 10 9 8 6 12 10 11 9 10 
F6 20 14 31 18 16 16 21 19 17 19 21 21^ 
F8 14 23 14 18 12 13 17 15 22 11 19 13 
F9 19 20 23 14 18 17 17 15 15 18 22 22 
M1 11 16 14 16 10 18 11 16 13 17 13 16 
M2 17 21 15 19 13 20 21 26 21 27 20 31 
M3 5 7 4 9 5 7 5 7 5 4 7 6 
M4 17 14 16 14 18 12 16 13 14 18 13 24 
M7 22 25 37 29 39 26 39 34 35 38 54 34 
M8 15 11 11 11 7 12 12 13 13 14 17 17 
M9 46 65 54 70 52 66 74 77 57 84 68 68 
M10 34 16 20 12 20 16 18 21 30 13 21 12 





Table 37: Caffeine (ng/mL) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
34 km 
ED PLA ED PLA ED PLA 
F1 102 108 2396 127 2899 88 
F3 2643 1439 3410 1485 2205 1428 
F4 1097 1302 2831 1283 3697 1790 
F5 1698 1089 2474 1890 2865 1669 
F6 469 820 2297 451 2703 482^ 
F8 45 22 1450 28 1405 18 
F9 80 110 1363 98 3238 99 
M1 43 111 2186 98 1962 86 
M2 190 115 509 126 712 89 
M3 108 44 2525 44 2923 43 
M4 1611 168 3015 226 2713 173 
M7 1567 1422 3236 1330 3898 872 
M8 321 146 2598 161 2249 111 
M9 2205 2176 3484 1593 3316 1330 
M10 820 135 2473 119 2439 80 






Table 38: Epinephrine (pg/mL) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
17 km 29 km 34 km 
ED PLA ED PLA ED PLA ED PLA ED PLA 
F1 149 128 139 92 349 305 260 286 559 417 
F3 123 78 117 108 374 146 367 174 330 206 
F4 82 128 148 86 613 322 609 355 605 374 
F5 130 126 190 90 417 282 426 316 422 302 
F6 0 32 12 0 128 235 243 211 319 218^ 
F8 29 18 58 5 542 183 496 182 682 247 
F9 14 0 2 30 458 115 557 112 935 121 
M1 96 74 68 63 439 207 489 204 589 273 
M2 71 78 48 72 597 322 892 430 1464 1211 
M3 102 102 71 52 435 225 384 277 454 294 
M4 79 53 52 54 589 199 769 214 481 144 
M7 0 49 0 34 579 302 548 293 723 323 
M8 13 0 0 0 510 331 454 271 581 375 
M9 30 0 0 0 444 171 483 216 518 238 
M10 226 0 0 0 650 285 658 377 764 489 





Table 50: Norepinephrine (pg/mL) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
17 km 29 km 34 km 
ED PLA ED PLA ED PLA ED PLA ED PLA 
F1 300 302 1196 565 3090 2829 1861 2780 1815 1947 
F3 371 675 508 1040 1136 2079 1481 1344 1391 1581 
F4 136 96 713 489 4264 2426 2203 2157 2487 2900 
F5 305 224 199 988 554 1064 787 1301 1216 721 
F6 143 143 398 307 4150 1625 3986 2144 2408 2443^
F8 340 143 347 261 3785 2664 3617 2103 4555 2812 
F9 407 182 520 570 2396 1446 3546 1518 4268 1686 
M1 479 557 803 1235 3434 2908 4187 2973 3992 3391 
M2 625 729 1379 1418 4796 4660 4307 4954 5040 4937 
M3 398 430 538 693 2362 1527 2151 2184 2307 2537 
M4 411 432 849 511 2254 1631 3627 1779 2647 2402 
M7 435 631 513 776 3612 3214 3687 2829 3543 2983 
M8 580 602 1055 1676 2770 2692 2289 2670 2530 3421 
M9 438 363 558 525 2541 1637 2401 1595 2266 1238 
M10 544 175 707 394 1597 1186 1357 1102 1371 1297 





Table 39: β-Endorphins (ng/mL) 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
34 km 
ED PLA ED PLA ED PLA 
F1 0.06 0.08 0.04 0.05 .04 .06 
F3 0.04 0.03 0.02 0.03 0.06 0.08 
F4 0.04 0.03 0.03 0.04 0.05 0.05 
F5 0.03 0.02 0.02 0.03 0.04 0.04 
F6 0.03 0.05 0.03 0.04 .06^ .05 
F8 0.04 0.04 0.03 0.03 0.08 0.07 
F9 0.03 0.05 0.04 0.04 0.05 0.05 
M1 0.03 0.03 0.05 0.35 0.05 0.05 
M2 0.08 0.05 0.04 0.05 0.07 0.08 
M3 0.04 0.06 0.05 0.04 0.06 0.06 
M4 0.01 0.03 0.03 0.03 0.04 0.03 
M7 0.05 0.05 0.05 0.07 0.15 0.08 
M8 0.04 0.05 0.02 0.04 0.07 0.07 
M9 0.04 0.02 0.03 0.00 0.04 0.03 
M10 0.05 0.06 0.03 0.06 0.07 0.16 






Table 40: Cortisol (µg/dL) Start to 17 km 
Participant 
Pre Drink Pre 
Race 
Post Drink Pre 
Race 
6 km 17 km 
ED PLA ED PLA ED PLA ED PLA 
F1 31 21 24 28 22 23 18 24 
F3 20 15 20 13 17 19 26 24 
F4 26 20 27 19 23 24 33 29 
F5 24 25 25 22 25 29 29 28 
F6 43 51 38 49 39 37 45 46 
F8 21 25 22 19 24 22 34 33 
F9 31 41 34 35 27 31 26 28 
M1 45 25 39 27 37 20 30 20 
M2 18 25 27 26 34 29 34 32 
M3 19 18 20 15 22 15 26 20 
M4 44 52 42 47 53 44 69 46 
M7 24 21 28 16 23 16 29 25 
M8 27 31 23 25 25 21 29 29 
M9 24 21 17 16 17 13 27 18 





Table 41: Cortisol (µg/dL) 23 km to 34 km 
Participant 
23 km 29 km 34 km 
ED PLA ED PLA ED PLA 
F1 15 32 15 35 14 35 
F3 31 21 31 18 31 20 
F4 34 31 41 38 37 34 
F5 32 29 37 24 36 28 
F6 44 44 46 39 50 45^ 
F8 38 44 38 31 41 30 
F9 27 26 32 27 31 27 
M1 29 20 27 21 25 21 
M2 36 36 38 33 39 34 
M3 31 20 28 20 26 20 
M4 70 57 68 55 57 54 
M7 33 28 30 29 36 29 
M8 34 36 35 36 35 37 
M9 30 18 32 19 32 20 
M10 26 37 32 40 36 35 




APPENDIX C: STUDY SUPPLEMENT DETAIL 
 ED PLA 
Energy (kcal) 200 0 
Carbohydrate 54 g 0 g 
Caffeine 160 mg 0 mg 
Taurine 2000 mg 0 mg 
Panax Ginseng 400 mg 0 mg 
Proprietary Energy Blend 
(L-Carnitine, Guaraná, 
Glucuronolactone) 












0 .745 .745 
Random between 
-3% and 3% 
.745 .005 .75 0% 
.75 .5 1.25 0% 
1.25 3.495 4.745 
Random between 
-3% and 3% 
4.745 .005 4.75 0% 
4.75 3.5 8.25 0% 
8.25 3.495 11.745 
Random between 
-3% and 3% 
11.745 .005 11.75 5.4% 
11.75 .5 12.25 5.4% 
12.25 3.495 15.745 
Random between 
-3% and 3% 
15.745 .005 15.75 0% 
15.75 3.5 19.25 0% 
19.25 3.495 22.745 
Random between 
-3% and 3% 
22.745 .005 22.75 5.4% 
22.75 .5 23.25 5.4% 
23.25 4.495 27.745 
Random between 
-3% and 3% 
27.745 .005 27.75 0% 
27.75 3.5 31.25 0% 
31.25 2.495 33.745 
Random between 
-3% and 3% 
33.745 .005 33.75 5.4% 
33.75 .5 34.25 5.4% 
34.25 .75 35 
Random between 
-3% and 3% 
 
 114
APPENDIX E: FIGURES OF RESULTS 
Figures appear in this section to give a visual representation of data. When a 
significant interaction or main effect was found, post-hoc analysis was utilized using the 
LSD method. Treatment-by-time interactions are indicated with an asterisk (*), main 
effects for treatment when no interaction was found are indicated by an ampersand (&) 
and main effects for time when no interaction was found are indicated by different letters 
(A-G). 
Physical Performance 
Figure 1: Race Performance by Treatment 
 




















Figure 2: Rating of Perceived Exertion 
 
A-GSignificant differences in times. Participants were riding up a simulated hill at 12 
km, 23 km, and 34 km which resulted in peaks in RPE at these times.  
Cognitive and Psychomotor Performance 
Figure 3: Tap Test, Percent of Precise Responses 
 






























Figure 4: Executive Function Test, Total Time 
 
&Main effect for treatment was found. The effect is probably due to confounds 
which caused participants to perform the task faster on the day they received ED 
and not due to the treatment since no time by treatment interaction was found. 
Figure 5: Stroop Test, Reaction Time to All Stimuli 
 
A,BMain effect of time. The data indicate that participants reacted faster regardless 
of stimulus type while exercising at 70% of VO2max immediately after completing the 
































Figure 6: Stroop Test, Reaction Time to Incongruent Stimuli 
 
A,BMain effect of time when presented with "incongruent" stimuli.  
Figure 7: Tap Test, Simple Movement Time 
 
*Treatment-by-time interaction. ED resulted in increased taps per second prior to 
exercise onset as well as after completion of the 35-km time trial. Conclusions can be 
made about ED since participants performed at the same level prior to drinking. 






































Figure 8: Executive Function Test, Simple Movement 
 
&Main effect for treatment. Similar to Executive Function Total Time (&Main effect 
for treatment was found. The effect is probably due to confounds which caused 
participants to perform the task faster on the day they received ED and not due to 
the treatment since no time by treatment interaction was found.), the main effect for 
treatment is likely due to uncontrolled factors. A,BMain effect for time indicating 
faster movement time after exercise. 
Figure 9: Executive Function Test, Gross Movement Time 
 
A-CMain effect for time. Gross movement during the executive function test was 








































Figure 10: Reaction Time Test, Gross Movement Time when Correct 
 
A-CMain effect of time. Gross movement during the reactive time test was faster 
after exercise. 
Metabolic Effects 
Figure 11: Insulin 
  
*Treatment-by-time interaction. Insulin spiked when participants received ED but 















































Figure 12: Glucose 
 
*Treatment-by-time interaction. Glucose is maintained by the insulin spike so that 
there is no difference between ED and PLA before the race starts. When the race 
starts, glucose fell in ED due to the lasting effects of insulin, though there is no 
difference by 23 km. &Main effect for treatment was also found. 
Figure 13: Free Fatty Acids 
 
Figure 7 *Treatment-by-time. Free fatty acids fell after the insulin spike induced by 
ED, but the exercise stimulus increased lipolysis. By 29 km there is no difference 






















































Figure 14: Glycerol 
 
A-FMain effect of time. At rest there is no change in glycerol, but over the course of 
the 35-km race increased lipolysis causes increased blood glycerol. 
Figure 15: Caffeine 
 
*Treatment-by-time interaction. ED elevated caffeine throughout the race. &Main 

















































Figure 16: Epinephrine 
 
*Treatment-by-time interaction. ED elevated epinephrine levels over PLA once 
exercise started. These levels remained elevated throughout exercise. &Main effect 
for treatment was also found. 
Figure 17: Norepinephrine 
 
*Treatment-by-time interaction. ED caused norepinephrine to be elevated at 17 km 
more than PLA, though there were no differences through the end of the trial. 












































Figure 18: β-Endorphins 
 
A-CMain effect of time. β-endorphins fell while participants were resting before 
exercise but the rose throughout the race. 
Figure 19: Cortisol 
 
A-DMain effect of time. Cortisol rose due to exercise by 23 km and remained elevated 















































Figure 20: Lactate 
 
*Treatment-by-time interaction. ED increased lactate more than PLA starting at 
rest and continuing throughout the exercise trial. &Main effect for treatment. 
Figure 21: Myoglobin 
 
A-EMain effect for time. While there is slight variation from time to time, myoglobin 

















































Figure 22: VO2 
 
&Main effect for treatment. A,BMain effect for time. ED resulted in greater oxygen 
consumption throughout the ride though VO2 fell as exercise progressed regardless 
of drink provided. 
Figure 23: Respiratory Exchange Ratio 
 

































Figure 24: Heart Rate 
 































































































APPENDIX F: FORMULAS 






	 	  
 
	 	  
 
	 	 	 	 	 	 	 	 	 	 	 	  
 
	 	  
 
	 	 	 	 	 	 	 	 	 	 	 	  
 







 I II III IV V 
Treatments 
A 32.3 34 34.3 35 36.5 172.1 
B 33.3 33 36.3 36.8 34.5 173.9 
C 30.8 34.3 35.3 32.3 35.8 168.5 
D x 26 29.8 28 28.8 112.6 
Block Total (ƩXj) 96.4 127.3 135.7 132.1 135.6 627.1 
 
4 112.6 5 96.4 627.1








Equation 2: Estimating Maximal Heart Rate 
208 0.7
	 	  
	 	  
AN EXAMPLE FOR A 30 YEAR OLD PARTICIPANT: 









	 	 	  
	 	 	 	  
	 	 	 	 	  
AN EXAMPLE FOR ELICITING 50% OF VO2MAX IN A PARTICIPANT WITH VO2MAX OF 

















Total time (minutes) 0 5 10 30 35 75 90 95
% % % % % % % %
^ ^ ^ ^ ^
* * * * * * *
Total time (minutes) 100 102 110 111 114 117 121 128 129 132 135 139 149 150 153 158 160
Distance into time-trial ride (km) 0 1 5 6 8 10 12 16 17 19 20 23 28 29 31 34 35
Legend
@ = weigh
$ = Stroop @
$
#
% = HR %
 ̂= Blood Draw +
& = Give Drink 165 170 175
* = Rating of Perceived Exertion
Timeline for Experimental Rides
+ = Start 2 minute ride at 70% of 
VO2max
¶ = Start 5 minute warm-up ride at 
50% of VO2max
# = Tap, Reaction Time, Executive 
Function Tests
35 km time-trial ride
Gas Collection 1 Gas Collection 2 Gas Collection 3
Total time (minutes)
Part B: Throughout 35 km Time-Trial Ride
Part C: After 35 km Time-Trial Ride until Dismissal
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